BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004;145:5439-47. [PMID: 15331580 DOI: 10.1210/en.2004-0959] [Cited by in Crossref: 700] [Cited by in F6Publishing: 723] [Article Influence: 36.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Song G, Su M, Zhang H, Yang T, Song Z. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of CCND1. Environ Toxicol 2023. [PMID: 36947456 DOI: 10.1002/tox.23761] [Reference Citation Analysis]
2 Tarle M, Raguž M, Muller D, Lukšić I. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma. Int J Mol Sci 2023;24:5816. [PMID: 36982894 DOI: 10.3390/ijms24065816] [Reference Citation Analysis]
3 Fedorova V, Amruz Cerna K, Oppelt J, Pospisilova V, Barta T, Mraz M, Bohaciakova D. MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro. Stem Cell Rev Rep 2023. [PMID: 36918496 DOI: 10.1007/s12015-023-10524-2] [Reference Citation Analysis]
4 Pallauf M, Ged Y, Singla N. Molecular differences in renal cell carcinoma between males and females. World J Urol 2023. [PMID: 36905442 DOI: 10.1007/s00345-023-04347-6] [Reference Citation Analysis]
5 Li Y, Liu C, Bai X, Li M, Duan C. FK506 binding protein 5 regulates cell quiescence-proliferation decision in zebrafish epithelium.. [DOI: 10.1101/2023.03.02.530846] [Reference Citation Analysis]
6 Sofiani VH, Veisi P, Rukerd MRZ, Ghazi R, Nakhaie M. The complexity of human papilloma virus in cancers: a narrative review. Infect Agent Cancer 2023;18:13. [PMID: 36843070 DOI: 10.1186/s13027-023-00488-w] [Reference Citation Analysis]
7 Zangouei AS, Zangoue M, Taghehchian N, Zangooie A, Rahimi HR, Saburi E, Alavi MS, Moghbeli M. Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis. Biol Res 2023;56:1. [PMID: 36597150 DOI: 10.1186/s40659-022-00411-4] [Reference Citation Analysis]
8 Xie B, Johal N, Millar M, Thrasivoulou C, Kanai A, Ahmed A, Fry C. Quantification of the TGF- β/SMAD fibrosis pathway in bladder wall samples from children with congenital lower urinary tract anomalies. Continence 2023. [DOI: 10.1016/j.cont.2023.100573] [Reference Citation Analysis]
9 Mir MA, Gul A, Sofi S, Khan MS. CDk Inhibitor for Treatment of Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 2023. [DOI: 10.1007/978-981-19-8911-7_15] [Reference Citation Analysis]
10 Mir MA, Qayoom H. Different Cyclins and Their Significance in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer 2023. [DOI: 10.1007/978-981-19-8911-7_17] [Reference Citation Analysis]
11 Gattupalli M, Dey P, Poovizhi S, Patel RB, Mishra D, Banerjee S. The Prospects of RNAs and Common Significant Pathways in Cancer Therapy and Regenerative Medicine. Regenerative Medicine 2023. [DOI: 10.1007/978-981-19-6008-6_16] [Reference Citation Analysis]
12 Karabağ S, Erdoğan K, Mirioğlu A, Zorlu Ö, Gönlüşen G, Özbarlas S. Pathogenetic and Prognostic Importance of Cyclin D1, Estrogen Receptor, and TAG72 in Cutaneous Vascular Tumors and Pericytic Tumors. jarem 2022;12:137-142. [DOI: 10.4274/jarem.galenos.2022.35220] [Reference Citation Analysis]
13 Delgado-garcia LM, Benincasa JC, Courbassier NR, Ribeiro TN, Porcionatto M. Contribution of Notch/Wnt signaling modulation in reactive astrocyte reparative response after brain injury.. [DOI: 10.1101/2022.12.20.521209] [Reference Citation Analysis]
14 Gerasymchuk M, Robinson GI, Groves A, Haselhorst L, Nandakumar S, Stahl C, Kovalchuk O, Kovalchuk I. Phytocannabinoids Stimulate Rejuvenation and Prevent Cellular Senescence in Human Dermal Fibroblasts. Cells 2022;11. [PMID: 36497198 DOI: 10.3390/cells11233939] [Reference Citation Analysis]
15 Trac N, Oh HS, Jones LI, Caliliw R, Ohtake S, Shuch B, Chung EJ. CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells. Molecules 2022;27. [PMID: 36500549 DOI: 10.3390/molecules27238457] [Reference Citation Analysis]
16 Bhowmick S, Singh S, Ahmad S, Mishra JK. Dual Roles of Cyclin D1 in Normal Physiology and Disease. AJOHAS 2022;12:9. [DOI: 10.25259/ajohas_10_2022] [Reference Citation Analysis]
17 Liu Y, Shang G, Zhang X, Liu F, Zhang C, Li Z, Jia J, Xu Y, Zhang Z, Yang S, Zhou B, Luan Y, Huang Y, Peng Y, Han T, He Y, Zheng H. CAMTA1 gene affects the ischemia-reperfusion injury by regulating CCND1. Front Cell Neurosci 2022;16:868291. [DOI: 10.3389/fncel.2022.868291] [Reference Citation Analysis]
18 Wang F, van Baal J, Ma L, Gao X, Dijkstra J, Bu D. MRCKα is a novel regulator of prolactin-induced lactogenesis in bovine mammary epithelial cells. Animal Nutrition 2022;10:319-328. [DOI: 10.1016/j.aninu.2022.06.001] [Reference Citation Analysis]
19 Chen S, Li L. Degradation strategy of cyclin D1 in cancer cells and the potential clinical application. Front Oncol 2022;12:949688. [DOI: 10.3389/fonc.2022.949688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Thorenoor N, Floros J. The Lung Alveolar Cell (LAC) miRNome and Gene Expression Profile of the SP-A-KO Mice After Infection With and Without Rescue With Human Surfactant Protein-A2 (1A0). Front Immunol 2022;13:854434. [DOI: 10.3389/fimmu.2022.854434] [Reference Citation Analysis]
21 Markkanen A, Aro K, Laury AR, Mäkitie AA, Haglund C, Atula T, Hagström J. Increased MIB-1 expression in salivary gland pleomorphic adenoma that recurs and undergoes malignant transformation. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13082-8] [Reference Citation Analysis]
22 Rintz E, Węgrzyn G, Fujii T, Tomatsu S. Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide. Int J Mol Sci 2022;23. [PMID: 35682595 DOI: 10.3390/ijms23115916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhu DD, Yu XB, Jiang W, Zhu Y. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p. Bioengineered 2022;13:13607-21. [PMID: 35765893 DOI: 10.1080/21655979.2022.2081464] [Reference Citation Analysis]
24 Habara M, Sato Y, Goshima T, Sakurai M, Imai H, Shimizu H, Katayama Y, Hanaki S, Masaki T, Morimoto M, Nishikawa S, Toyama T, Shimada M. FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer. Proc Natl Acad Sci U S A 2022;119:e2110256119. [PMID: 35394865 DOI: 10.1073/pnas.2110256119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kortam MA, Alawady AS, Hamid Sadik NA, Fathy N. Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats. Archives of Biochemistry and Biophysics 2022. [DOI: 10.1016/j.abb.2022.109237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Zhao A, Li D, Mao X, Yang M, Deng W, Hu W, Chen C, Yang G, Li L. GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling. Cell Death Dis 2022;13:260. [PMID: 35322009 DOI: 10.1038/s41419-022-04690-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Peng KY, Chou TC. Osthole Exerts Inhibitory Effects on Hypoxic Colon Cancer Cells via EIF2[Formula: see text] Phosphorylation-mediated Apoptosis and Regulation of HIF-1[Formula: see text]. Am J Chin Med 2022;50:621-37. [PMID: 35114913 DOI: 10.1142/S0192415X22500240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Termine A, Fabrizio C, Strafella C, Caputo V, Petrosini L, Caltagirone C, Cascella R, Giardina E. A Hybrid Machine Learning and Network Analysis Approach Reveals Two Parkinson's Disease Subtypes from 115 RNA-Seq Post-Mortem Brain Samples. Int J Mol Sci 2022;23. [PMID: 35269707 DOI: 10.3390/ijms23052557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Chen ME, Naeini SM, Srikrishnaraj A, Drucker DJ, Fesler Z, Brubaker PL. Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells. Cell Mol Gastroenterol Hepatol 2022;13:1829-42. [PMID: 35218981 DOI: 10.1016/j.jcmgh.2022.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Jiang Z, Li H, Schroer SA, Voisin V, Ju Y, Pacal M, Erdmann N, Shi W, Chung PED, Deng T, Chen NJ, Ciavarra G, Datti A, Mak TW, Harrington L, Dick FA, Bader GD, Bremner R, Woo M, Zacksenhaus E. Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetes. EMBO J 2022;:e106825. [PMID: 35023164 DOI: 10.15252/embj.2020106825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Garces S, Medeiros LJ, Marques-Piubelli ML, Coelho Siqueira SA, Miranda RN, Cuglievan B, Sriganeshan V, Medina AM, Garces JC, Saluja K, Bhattacharjee MB, Khoury JD, Li S, Xu J, Jelloul FZ, Thakral B, Cameron Yin C. Cyclin D1 expression in Rosai-Dorfman disease: A near constant finding that is not invariably associated with MAPK/ERK pathway activation. Hum Pathol 2022:S0046-8177(21)00221-5. [PMID: 34995673 DOI: 10.1016/j.humpath.2021.12.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
32 Anitha J, Selvakumar R, Hema S, Murugan K, Premkumar T. Facile green synthesis of nano-sized ZnO using leaf extract of Morinda tinctoria: MCF-7 cell cycle arrest, antiproliferation, and apoptosis studies. Journal of Industrial and Engineering Chemistry 2022;105:520-9. [DOI: 10.1016/j.jiec.2021.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Liu J, Tao L, Yu G, Chen G, Wang Z, Mei K, Xu X, Shi X, Li T, Yin W. Diagnostic significance of CyclinD1 and D2-40 expression for follicular neoplasm of the thyroid. Pathology - Research and Practice 2022;229:153739. [DOI: 10.1016/j.prp.2021.153739] [Reference Citation Analysis]
34 Mustafa K, Yu S, Mohamed H, Qi T, Xiao H, ciali S, Yang W, Naz T, Nosheen S, Bai X, Song Y. Comparative Study on the Role of Berberine and Berberis lycium Royle Roots Extract against the Biochemical Markers and Cyclin D1 Expression in HCC Animal Model. Applied Sciences 2021;11:11810. [DOI: 10.3390/app112411810] [Reference Citation Analysis]
35 Converse A, Thomas P. Androgens promote vascular endothelial cell proliferation through activation of a ZIP9-dependent inhibitory G protein/PI3K-Akt/Erk/cyclin D1 pathway. Mol Cell Endocrinol 2021;538:111461. [PMID: 34555425 DOI: 10.1016/j.mce.2021.111461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
36 Davari DR, Orlow I, Kanetsky PA, Luo L, Busam KJ, Sharma A, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Gibbs DC, Ollila DW, Begg CB, Berwick M, Thomas NE. Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study. Curr Oncol 2021;28:4756-71. [PMID: 34898573 DOI: 10.3390/curroncol28060401] [Reference Citation Analysis]
37 Augusto TV, Amaral C, Almeida CF, Teixeira N, Correia-da-Silva G. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells. Mol Cell Endocrinol 2021;537:111426. [PMID: 34391846 DOI: 10.1016/j.mce.2021.111426] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Pachva MC, Lai H, Jia A, Rouleau M, Sorensen PH. Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment. Front Cell Dev Biol 2021;9:726205. [PMID: 34604225 DOI: 10.3389/fcell.2021.726205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Nkwe DO, Lotshwao B, Rantong G, Matshwele J, Kwape TE, Masisi K, Gaobotse G, Hefferon K, Makhzoum A. Anticancer Mechanisms of Bioactive Compounds from Solanaceae: An Update. Cancers (Basel) 2021;13:4989. [PMID: 34638473 DOI: 10.3390/cancers13194989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Al Kafri N, Hafizi S. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells. Biochem Biophys Rep 2021;28:101111. [PMID: 34471705 DOI: 10.1016/j.bbrep.2021.101111] [Reference Citation Analysis]
41 Tong H, Ding Y, Gui X, Sun Z, Wang G, Zhang S, Xu Z, Wang X, Xu X, Ju W, Li Y, Li Z, Zeng L, Xu K, Qiao J. Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse. Thromb J 2021;19:61. [PMID: 34454532 DOI: 10.1186/s12959-021-00314-6] [Reference Citation Analysis]
42 Sahu R, Pattanayak SP. Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets. Curr Gene Ther 2020;20:237-58. [PMID: 32807051 DOI: 10.2174/1566523220999200731002408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
43 Lee HN, Choi YS, Kim SH, Zhong X, Kim W, Park JS, Saeidi S, Han BW, Kim N, Lee HS, Choi YJ, Baek JH, Na HK, Surh YJ. Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality. FASEB J 2021;35:e21432. [PMID: 33794029 DOI: 10.1096/fj.202002392R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hong YA, Park KC, Kim BK, Lee J, Sun WY, Sul HJ, Hwang KA, Choi WJ, Chang YK, Kim SY, Shin S, Park J. Analyzing Genetic Differences Between Sporadic Primary and Secondary/Tertiary Hyperparathyroidism by Targeted Next-Generation Panel Sequencing. Endocr Pathol 2021. [PMID: 34215996 DOI: 10.1007/s12022-021-09686-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Akbari A, Sedaghat M, Heshmati J, Tabaeian SP, Dehghani S, Pizarro AB, Rostami Z, Agah S. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers. Biomed Pharmacother 2021;141:111849. [PMID: 34214729 DOI: 10.1016/j.biopha.2021.111849] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Nowak B, Rogujski P, Janowski M, Lukomska B, Andrzejewska A. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all. Biochim Biophys Acta Rev Cancer 2021;1876:188582. [PMID: 34144129 DOI: 10.1016/j.bbcan.2021.188582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
47 Ribas-Latre A, Santos RB, Fekry B, Tamim YM, Shivshankar S, Mohamed AMT, Baumgartner C, Kwok C, Gebhardt C, Rivera A, Gao Z, Sun K, Heiker JT, Snyder BE, Kolonin MG, Eckel-Mahan KL. Cellular and physiological circadian mechanisms drive diurnal cell proliferation and expansion of white adipose tissue. Nat Commun 2021;12:3482. [PMID: 34108488 DOI: 10.1038/s41467-021-23770-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
48 Zhang L, Lu SY, Guo R, Ma JX, Tang LY, Wang JJ, Shen CL, Lu LM, Liu J, Wang ZG, Zhang HX. STK10 knockout inhibits cell migration and promotes cell proliferation via modulating the activity of ERM and p38 MAPK in prostate cancer cells. Exp Ther Med 2021;22:851. [PMID: 34149897 DOI: 10.3892/etm.2021.10283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Yang Y, Lu T, Li Z, Lu S. FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer. Cell Adh Migr 2020;14:82-95. [PMID: 32380883 DOI: 10.1080/19336918.2020.1766308] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
50 Berezovskaya AS, Tyganov SA, Nikolaeva SD, Naumova AA, Shenkman BS, Glazova MV. Plantar Stimulations during 3-Day Hindlimb Unloading Prevent Loss of Neural Progenitors and Maintain ERK1/2 Activity in the Rat Hippocampus. Life (Basel) 2021;11:449. [PMID: 34067876 DOI: 10.3390/life11050449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Weidle UH, Brinkmann U, Auslaender S. microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models. Cancer Genomics Proteomics 2020;17:453-68. [PMID: 32859626 DOI: 10.21873/cgp.20204] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Karamanou K, Franchi M, Proult I, Rivet R, Vynios D, Brézillon S. Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers. Cells 2021;10:841. [PMID: 33917849 DOI: 10.3390/cells10040841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
53 Paul EN, Burns GW, Carpenter TJ, Grey JA, Fazleabas AT, Teixeira JM. Transcriptome Analyses of Myometrium from Fibroid Patients Reveals Phenotypic Differences Compared to Non-Diseased Myometrium. Int J Mol Sci 2021;22:3618. [PMID: 33807176 DOI: 10.3390/ijms22073618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Lee KE, Choi DH, Joo C, Kang SW, Huh KM, Park YS. Octanoyl glycol chitosan enhances the proliferation and differentiation of tonsil-derived mesenchymal stem cells. Carbohydr Polym 2021;264:117992. [PMID: 33910730 DOI: 10.1016/j.carbpol.2021.117992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Deng D, Mo Y, Xue L, Shao N, Cao J. Long non-coding RNA SUMO1P3 promotes tumour progression by regulating cell proliferation and invasion in glioma. Exp Ther Med 2021;21:491. [PMID: 33791000 DOI: 10.3892/etm.2021.9922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Xu S, Zhang T, Cao Z, Zhong W, Zhang C, Li H, Song J. Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights. Front Immunol 2021;12:638400. [PMID: 33790909 DOI: 10.3389/fimmu.2021.638400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Albrahim T, Alnasser MM, Al-Anazi MR, ALKahtani MD, Alkahtani S, Al-Qahtani AA. In Vitro Studies on the Immunomodulatory Effects of Pulicaria crispa Extract on Human THP-1 Monocytes. Oxid Med Cell Longev 2020;2020:7574606. [PMID: 33628359 DOI: 10.1155/2020/7574606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Zhang H, Zhang LQ, Yang CC, Li J, Tian XY, Li DN, Cui J, Cai JP. The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling. PLoS One 2021;16:e0245876. [PMID: 33571243 DOI: 10.1371/journal.pone.0245876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Sencan S, Tanriover M, Ulasli M, Karakas D, Ozpolat B. UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cells. Mol Cell Biochem 2021;476:2075-84. [PMID: 33515382 DOI: 10.1007/s11010-021-04063-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Bloedjes TA, de Wilde G, Guikema JEJ. Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma. Cancers (Basel) 2021;13:396. [PMID: 33494394 DOI: 10.3390/cancers13030396] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
61 Eid BG, Abdel-Naim AB. Piceatannol Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Modulation of Nrf2/HO-1/NFκB Axis. Front Pharmacol 2020;11:614897. [PMID: 33519479 DOI: 10.3389/fphar.2020.614897] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
62 Lin Y, He Z, Ye J, Liu Z, She X, Gao X, Liang R. Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther 2020;13:13023-32. [PMID: 33376351 DOI: 10.2147/OTT.S278013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
63 Medda N, De SK, Maiti S. Different mechanisms of arsenic related signaling in cellular proliferation, apoptosis and neo-plastic transformation. Ecotoxicol Environ Saf 2021;208:111752. [PMID: 33396077 DOI: 10.1016/j.ecoenv.2020.111752] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
64 Li L, Hao J, Yan CQ, Wang HF, Meng B, Cai SY. Inhibition of microRNA-300 inhibits cell adhesion, migration, and invasion of prostate cancer cells by promoting the expression of DAB1. Cell Cycle 2020;19:2793-810. [PMID: 33064976 DOI: 10.1080/15384101.2020.1823730] [Reference Citation Analysis]
65 Moharil RB, Khandekar S, Dive A, Bodhade A. Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol 2020;24:397. [PMID: 33456254 DOI: 10.4103/jomfp.JOMFP_164_20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
66 Jin J, Guo Y, Dong X, Liu J, He Y. Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency. Radiotherapy and Oncology 2020;150:104-13. [DOI: 10.1016/j.radonc.2020.06.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
67 Sakai H, Murakami C, Usuki T, Lu Q, Matsumoto KI, Urano T, Sakane F. Diacylglycerol kinase η regulates C2C12 myoblast proliferation through the mTOR signaling pathway. Biochimie 2020;177:13-24. [PMID: 32791090 DOI: 10.1016/j.biochi.2020.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
68 Sommer G, Heise T. Role of the RNA-binding protein La in cancer pathobiology. RNA Biol 2021;18:218-36. [PMID: 32687431 DOI: 10.1080/15476286.2020.1792677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
69 Yang X, Wang S, Yu W, Zheng Y, Wu Y. Inhibition of ITGB1 enhance the anti-tumor effect of cetuximab in colorectal cancer cell. Medicine (Baltimore) 2020;99:e20944. [PMID: 32629699 DOI: 10.1097/MD.0000000000020944] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
70 Nikzad M, Mirdar S; Department of Mathematics, University of Science and Technology of Mazandaran, Iran, Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Mazandaran, Babolsar, Iran. Inhibitory effects of Nigella sativa nano-capsule on the expression of cyclin D1 in the lungs of wistar rats exposed to nicotine-derived nitrosamine ketone. J Med Plants 2020;19:118-28. [DOI: 10.29252/jmp.19.74.118] [Reference Citation Analysis]
71 Yaghoobi MM, Sheikoleslami M, Ebrahimi M. Effects of hydrogen peroxide, doxorubicin and ultraviolet irradiation on senescence of human dental pulp stem cells. Arch Oral Biol 2020;117:104819. [PMID: 32592933 DOI: 10.1016/j.archoralbio.2020.104819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
72 Zhang ZY, Zhang SL, Chen HL, Mao YQ, Li ZM, Kong CY, Han B, Zhang J, Chen YH, Xue W, Zhai W, Wang LS. The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma. Cell Prolif 2020;53:e12853. [PMID: 32537867 DOI: 10.1111/cpr.12853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
73 Laskar S, Kundu S, Das R, Choudhury Y, Ghosh SK. Clinically significant variants associated with nasopharyngeal carcinoma: Findings of a meta-analysis study. Meta Gene 2020;24:100688. [DOI: 10.1016/j.mgene.2020.100688] [Reference Citation Analysis]
74 Henamayee S, Banik K, Sailo BL, Shabnam B, Harsha C, Srilakshmi S, Vgm N, Baek SH, Ahn KS, Kunnumakkara AB. Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties. Molecules 2020;25:E2278. [PMID: 32408623 DOI: 10.3390/molecules25102278] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 16.3] [Reference Citation Analysis]
75 Yan B, Li Y, Min S, Zhang P, Xu B, Wang Z, Zhang W, Chen J, Luo G, Liu C. Effects of the Bone/Bone Marrow Microenvironments on Prostate Cancer Cells and CD59 Expression. Biomed Res Int 2020;2020:2753414. [PMID: 32337233 DOI: 10.1155/2020/2753414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Liu D, Li W, Zhong F, Yin J, Zhou W, Li S, Sun X, Xu J, Li G, Wen Y, Wang J, Hong M, Cheng Z, Yuan J, Dai L, Sun J, Wang J, Qiu C, Wang G, Zou C. METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer. Front Pharmacol 2020;11:178. [PMID: 32180726 DOI: 10.3389/fphar.2020.00178] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
77 Colapietro A, Gravina GL, Petragnano F, Fasciani I, Scicchitano BM, Beirinckx F, Pujuguet P, Saniere L, Van der Aar E, Musio D, De Felice F, Mattei V, Martellucci S, Maggio R, Tombolini V, Festuccia C, Marampon F. Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo. J Oncol 2020;2020:9342732. [PMID: 32184826 DOI: 10.1155/2020/9342732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
78 Wang SS, Huang ZG, Wu HY, He RQ, Yang LH, Feng ZB, Dang YW, Lu HP, Fang YY, Chen G. Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1. PeerJ 2020;8:e8409. [PMID: 32095323 DOI: 10.7717/peerj.8409] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chen CA, Chang JM, Yang YL, Chang EE, Chen HC. Macrophage migration inhibitory factor regulates integrin-β1 and cyclin D1 expression via ERK pathway in podocytes. Biomed Pharmacother 2020;124:109892. [PMID: 31986415 DOI: 10.1016/j.biopha.2020.109892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Ying Y, Li J, Xie H, Yan H, Jin K, He L, Ma X, Wu J, Xu X, Fang J, Wang X, Zheng X, Liu B, Xie L. CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Prolif 2020;53:e12751. [PMID: 31971654 DOI: 10.1111/cpr.12751] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
81 Miao B, Bauer AS, Hufnagel K, Wu Y, Trajkovic-Arsic M, Pirona AC, Giese N, Taipale J, Siveke JT, Hoheisel JD, Lueong S. The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation. Int J Cancer 2020;147:189-201. [PMID: 31846072 DOI: 10.1002/ijc.32831] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
82 Hendy GN, Arnold A. Molecular basis of parathyroid hormone overexpression. Principles of Bone Biology 2020. [DOI: 10.1016/b978-0-12-814841-9.00058-0] [Reference Citation Analysis]
83 Lai X, Eberhardt M, Schmitz U, Vera J. Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer. Nucleic Acids Res 2019;47:7753-66. [PMID: 31340025 DOI: 10.1093/nar/gkz638] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 23.0] [Reference Citation Analysis]
84 Fardoun M, Iratni R, Dehaini H, Eid A, Ghaddar T, El-Elimat T, Alali F, Badran A, Eid AH, Baydoun E. 7-O-methylpunctatin, a Novel Homoisoflavonoid, Inhibits Phenotypic Switch of Human Arteriolar Smooth Muscle Cells. Biomolecules 2019;9:E716. [PMID: 31717401 DOI: 10.3390/biom9110716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
85 Saeed-Zidane M, Tesfaye D, Mohammed Shaker Y, Tholen E, Neuhoff C, Rings F, Held E, Hoelker M, Schellander K, Salilew-Wondim D. Hyaluronic acid and epidermal growth factor improved the bovine embryo quality by regulating the DNA methylation and expression patterns of the focal adhesion pathway. PLoS One 2019;14:e0223753. [PMID: 31661494 DOI: 10.1371/journal.pone.0223753] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
86 Kim EK, Jang M, Song MJ, Kim D, Kim Y, Jang HH. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells. Antioxidants (Basel) 2019;8:E471. [PMID: 31658599 DOI: 10.3390/antiox8100471] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
87 Guo W, Huang J, Wang N, Tan HY, Cheung F, Chen F, Feng Y. Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma. Front Pharmacol 2019;10:1185. [PMID: 31649545 DOI: 10.3389/fphar.2019.01185] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 19.8] [Reference Citation Analysis]
88 Qi Y, Wang D, Huang W, Wang B, Huang D, Xiong F, Chen X, Chen Y. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res 2019;38:413. [PMID: 31590696 DOI: 10.1186/s13046-019-1415-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
89 Cantu D, Alvarado Y, Murata-collins J, Weisenburger DD. Blastic transformation of mantle cell lymphoma with B-lymphoblastic features. Human Pathology: Case Reports 2019;17:200313. [DOI: 10.1016/j.ehpc.2019.200313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Militello AM, Zielli T, Boggiani D, Michiara M, Naldi N, Bortesi B, Zanelli P, Uliana V, Giuliotti S, Musolino A. Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Front Oncol 2019;9:759. [PMID: 31456944 DOI: 10.3389/fonc.2019.00759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
91 Chang C, Wang H, Liu J, Pan C, Zhang D, Li X, Pan Y. Porphyromonas gingivalis Infection Promoted the Proliferation of Oral Squamous Cell Carcinoma Cells through the miR-21/PDCD4/AP-1 Negative Signaling Pathway. ACS Infect Dis 2019;5:1336-47. [PMID: 31243990 DOI: 10.1021/acsinfecdis.9b00032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
92 Mahzouni P, Taheri F. An Immunohistochemical Study of Cyclin D1 Expression in Astrocytic Tumors and its Correlation with Tumor Grade. Iran J Pathol 2019;14:252-7. [PMID: 31583003 DOI: 10.30699/ijp.2019.82024.1771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
93 de Vasconcelos Azevedo FVP, Zóia MAP, Lopes DS, Gimenes SN, Vecchi L, Alves PT, Rodrigues RS, Silva ACA, Yoneyama KAG, Goulart LR, de Melo Rodrigues V. Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells. International Journal of Biological Macromolecules 2019;135:261-73. [DOI: 10.1016/j.ijbiomac.2019.05.164] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
94 Lemieszek MK, Nunes FM, Marques G, Rzeski W. Cantharellus cibarius branched mannans inhibits colon cancer cells growth by interfering with signals transduction in NF-ĸB pathway. International Journal of Biological Macromolecules 2019;134:770-80. [DOI: 10.1016/j.ijbiomac.2019.05.072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
95 Chen W, Peng R, Sun Y, Liu H, Zhang L, Peng H, Zhang Z. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR‐449a/b/Trim11/Mek signaling pathway. FASEB j 2019;33:11492-506. [DOI: 10.1096/fj.201900522r] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
96 Sukswai N, Khoury JD. Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection. Curr Hematol Malig Rep 2019;14:368-75. [DOI: 10.1007/s11899-019-00533-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
97 Murase T, Ri M, Narita T, Fujii K, Masaki A, Iida S, Inagaki H. Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma. Cancer Sci 2019;110:2600-6. [PMID: 31218784 DOI: 10.1111/cas.14109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
98 Yamamoto K, Kawai M, Yamazaki M, Tachikawa K, Kubota T, Ozono K, Michigami T. CREB activation in hypertrophic chondrocytes is involved in the skeletal overgrowth in epiphyseal chondrodysplasia Miura type caused by activating mutations of natriuretic peptide receptor B. Hum Mol Genet 2019;28:1183-98. [PMID: 30544148 DOI: 10.1093/hmg/ddy428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
99 Roy NK, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar NS, Singh AK, Bordoloi D, Baruah MN, Ahmed GN, Longkumar I, Arfuso F, Kumar AP, Kunnumakkara AB. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. Biomolecules 2019;9:E253. [PMID: 31252679 DOI: 10.3390/biom9070253] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
100 Di Sante G, Pagé J, Jiao X, Nawab O, Cristofanilli M, Skordalakes E, Pestell RG. Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology. Expert Rev Anticancer Ther 2019;19:569-87. [PMID: 31219365 DOI: 10.1080/14737140.2019.1615889] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
101 Mathew OP, Ranganna K, Mathew J, Zhu M, Yousefipour Z, Selvam C, Milton SG. Cellular Effects of Butyrate on Vascular Smooth Muscle Cells are Mediated through Disparate Actions on Dual Targets, Histone Deacetylase (HDAC) Activity and PI3K/Akt Signaling Network. Int J Mol Sci 2019;20:E2902. [PMID: 31197106 DOI: 10.3390/ijms20122902] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
102 Zhao Y, Xiang R, Peng X, Dong Q, Li D, Yu G, Xiao L, Qin S, Huang W. Transection of the cervical sympathetic trunk inhibits the progression of pulmonary arterial hypertension via ERK-1/2 Signalling. Respir Res 2019;20:121. [PMID: 31200778 DOI: 10.1186/s12931-019-1090-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
103 Chetina EV, Demidova NV, Markova GA. Metabolic aspects of clinical remission prediction from baseline blood gene expression in patients with rheumatoid arthritis treated with methotrexate. Sovremennaâ revmatologiâ 2019;13:47-54. [DOI: 10.14412/1996-7012-2019-2-47-54] [Reference Citation Analysis]
104 Ismail NI, Othman I, Abas F, H Lajis N, Naidu R. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int J Mol Sci 2019;20:E2454. [PMID: 31108984 DOI: 10.3390/ijms20102454] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 16.0] [Reference Citation Analysis]
105 Quan Q, Zheng Q, Ling Y, Fang F, Chu M, Zhang X, Liu Y, Li W. Comparative analysis of differentially expressed genes between the ovaries from pregnant and nonpregnant goats using RNA-Seq. J Biol Res (Thessalon) 2019;26:3. [PMID: 31080783 DOI: 10.1186/s40709-019-0095-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
106 Yuan XG, Huang YR, Yu T, Jiang HW, Xu Y, Zhao XY. Chidamide, a histone deacetylase inhibitor, induces growth arrest and apoptosis in multiple myeloma cells in a caspase-dependent manner. Oncol Lett. 2019;18:411-419. [PMID: 31289512 DOI: 10.3892/ol.2019.10301] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
107 Hosseini S, Chamani J, Hadipanah MR, Ebadpour N, Hojjati AS, Mohammadzadeh MH, Rahimi HR. Nano-curcumin's suppression of breast cancer cells (MCF7) through the inhibition of cyclinD1 expression. Breast Cancer (Dove Med Press) 2019;11:137-42. [PMID: 30936742 DOI: 10.2147/BCTT.S195800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
108 Kahl BS, Dreyling M, Gordon LI, Martin P, Quintanilla-Martinez L, Sotomayor EM. Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop. Leuk Lymphoma 2019;60:1853-65. [PMID: 30696305 DOI: 10.1080/10428194.2019.1571205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
109 Sun X, Wang M, Zhang F, Kong X. Inhibition of NET-1 suppresses proliferation and promotes apoptosis of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway. Exp Ther Med 2019;17:2334-40. [PMID: 30867719 DOI: 10.3892/etm.2019.7211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
110 Jiang J, Fan Y, Zhang W, Shen Y, Liu T, Yao M, Gu J, Tu H, Gan Y. Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway. Int J Biol Sci 2019;15:253-64. [PMID: 30745818 DOI: 10.7150/ijbs.27420] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
111 Gao Y, Chen Z, Wang R, Tan X, Huang C, Chen G, Chen Z. LXRα Promotes the Differentiation of Human Gastric Cancer Cells through Inactivation of Wnt/β-catenin Signaling. J Cancer 2019;10:156-67. [PMID: 30662536 DOI: 10.7150/jca.28600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
112 Prameswari K, Adi-kusumo F. A mathematical model for phase transition regulation on the cell cycle in early stage of breast cancer. AIP Conference Proceedings 2019. [DOI: 10.1063/1.5139160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Belső N, Gubán B, Manczinger M, Kormos B, Bebes A, Németh I, Veréb Z, Széll M, Kemény L, Bata-csörgő Z. Differential role of D cyclins in the regulation of cell cycle by influencing Ki67 expression in HaCaT cells. Experimental Cell Research 2019;374:290-303. [DOI: 10.1016/j.yexcr.2018.11.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
114 Tuan Anh HL, Tran PT, Thao DT, Trang DT, Dang NH, Van Cuong P, Kiem PV, Minh CV, Lee JH. Degalactotigonin, a Steroidal Glycoside from Solanum nigrum, Induces Apoptosis and Cell Cycle Arrest via Inhibiting the EGFR Signaling Pathways in Pancreatic Cancer Cells. Biomed Res Int 2018;2018:3120972. [PMID: 30643798 DOI: 10.1155/2018/3120972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
115 Li J, Liao X, Xiang Y, Yao A, Song R, Zhang Z, Huang F, Dai Z, Zhang T. Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1/S phase arrest. Gene 2018;679:232-40. [DOI: 10.1016/j.gene.2018.09.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
116 Smart SK, Vasileiadi E, Wang X, DeRyckere D, Graham DK. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer. Cancers (Basel) 2018;10:E474. [PMID: 30501104 DOI: 10.3390/cancers10120474] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
117 Chen H, Guan Y, Baek SJ, Zhong Q. Caffeic Acid Phenethyl Ester Loaded in Microemulsions: Enhanced In Vitro Activity against Colon and Breast Cancer Cells and Possible Cellular Mechanisms. Food Biophysics 2019;14:80-9. [DOI: 10.1007/s11483-018-9559-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 García-Reyes B, Kretz AL, Ruff JP, von Karstedt S, Hillenbrand A, Knippschild U, Henne-Bruns D, Lemke J. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2018;19:E3219. [PMID: 30340359 DOI: 10.3390/ijms19103219] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
119 Alçiğir ME, Şengel Türk CT, Ekim O, Hasçiçek C. Yetişkin ve Kastre Edilmiş Erkek Ratlarda Yüksek Doz Testosteron Propiyonatın İndüklediği Kardiyak Fibrozis Üzerine Lonidamin Yüklü Lipit-Polimer Hibrit Nanopartiküllerin Etkisi. Kocatepe Veterinary Journal 2018. [DOI: 10.30607/kvj.437999] [Reference Citation Analysis]
120 Dragnev KH, Whyman JD, Hahn CK, Kebbekus PE, Kokko SF, Bhatt SM, Rigas JR. A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer. J Thorac Dis 2018;10:5531-7. [PMID: 30416803 DOI: 10.21037/jtd.2018.09.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
121 Chang H, Li J, Cao Y, Liu T, Shi S, Chen W. Bufadienolides from Venenum Bufonis Inhibit mTOR-Mediated Cyclin D1 and Retinoblastoma Protein Leading to Arrest of Cell Cycle in Cancer Cells. Evid Based Complement Alternat Med 2018;2018:3247402. [PMID: 30108651 DOI: 10.1155/2018/3247402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
122 Lu Z, Huang F, Cao R, Tan G, Yi G, He N, Xu L, Zhang L. Intrinsic, Cancer Cell-Selective Toxicity of Organic Photothermal Nanoagent: A Simple Formulation for Combined Photothermal Chemotherapy of Cancer. ACS Appl Mater Interfaces 2018;10:26028-38. [DOI: 10.1021/acsami.8b07801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
123 Zhang Y, Chen S, Wei C, Rankin GO, Ye X, Chen YC. Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves attenuate chemotherapy-resistant ovarian cancer stem cell traits via targeting the Wnt/β-catenin signaling pathway and inducing G1 cell cycle arrest. Food Funct 2018;9:525-33. [PMID: 29256569 DOI: 10.1039/c7fo01453h] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
124 Kim JK, Gallaher DD, Trudo SP. Apiaceous vegetable intake modulates expression of DNA damage response genes and microRNA in the rat colon. Journal of Functional Foods 2018;45:138-45. [DOI: 10.1016/j.jff.2018.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
125 Sakai H, Murakami C, Matsumoto KI, Urano T, Sakane F. Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation. Biochimie 2018;151:45-53. [PMID: 29859210 DOI: 10.1016/j.biochi.2018.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
126 Giannattasio S, Megiorni F, Di Nisio V, Del Fattore A, Fontanella R, Camero S, Antinozzi C, Festuccia C, Gravina GL, Cecconi S, Dominici C, Di Luigi L, Ciccarelli C, De Cesaris P, Riccioli A, Zani BM, Lenzi A, Pestell RG, Filippini A, Crescioli C, Tombolini V, Marampon F. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines. J Endocrinol Invest 2019;42:183-97. [PMID: 29790086 DOI: 10.1007/s40618-018-0900-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
127 Jobani BM, Najafzadeh N, Mazani M, Arzanlou M, Vardin MM. Molecular mechanism and cytotoxicity of allicin and all-trans retinoic acid against CD44+ versus CD117+ melanoma cells. Phytomedicine 2018;48:161-9. [PMID: 30195874 DOI: 10.1016/j.phymed.2018.05.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
128 Rasouli S, Zarghami N. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression. Asian Pac J Cancer Prev 2018;19:977-82. [PMID: 29693804 DOI: 10.22034/APJCP.2018.19.4.977] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
129 Chen Y, Shang H, Zhang S, Zhang X. Retracted : Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down‐regulation of microRNA‐31. J Cell Biochem 2018;119:6527-34. [DOI: 10.1002/jcb.26716] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
130 Allam RM, Al-Abd AM, Khedr A, Sharaf OA, Nofal SM, Khalifa AE, Mosli HA, Abdel-Naim AB. Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicol Lett 2018;291:77-85. [PMID: 29654831 DOI: 10.1016/j.toxlet.2018.04.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
131 Song Y, Guo Q, Gao S, Hua K. Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer. Biochemical and Biophysical Research Communications 2018;498:686-92. [DOI: 10.1016/j.bbrc.2018.03.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
132 Li XG, Wang Z, Chen RQ, Fu HL, Gao CQ, Yan HC, Xing GX, Wang XQ. LGR5 and BMI1 Increase Pig Intestinal Epithelial Cell Proliferation by Stimulating WNT/β-Catenin Signaling. Int J Mol Sci 2018;19:E1036. [PMID: 29601474 DOI: 10.3390/ijms19041036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
133 Shen J, Zhu B. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes. Mol Med Rep 2018;17:7636-44. [PMID: 29620215 DOI: 10.3892/mmr.2018.8804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
134 Liu J, Jin P, Lin X, Zhou Q, Wang F, Liu S, Xi S. Arsenite increases Cyclin D1 expression through coordinated regulation of the Ca2+/NFAT2 and NF-κB pathways via ERK/MAPK in a human uroepithelial cell line. Metallomics 2018;10:486-95. [PMID: 29528074 DOI: 10.1039/c7mt00305f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
135 Kamarajugadda S, Becker JR, Hanse EA, Mashek DG, Mashek MT, Hendrickson AM, Mullany LK, Albrecht JH. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation. Oncotarget 2016;7:47674-86. [PMID: 27351284 DOI: 10.18632/oncotarget.10274] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
136 Reyes-sebastian J, Montiel-cervantes LA, Reyes-maldonado E, Dominguez-lopez ML, Ortiz-butron R, Castillo-alvarez A, Lezama RA. Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts. Hematology 2018;23:486-95. [DOI: 10.1080/10245332.2018.1444564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
137 Gruppetta M, Formosa R, Falzon S, Ariff Scicluna S, Falzon E, Degeatano J, Vassallo J. Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas. Pituitary 2017;20:358-71. [PMID: 28342098 DOI: 10.1007/s11102-017-0803-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
138 Wang R, Ding X, Zhou S, Li M, Sun L, Xu X, Fei G. Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1). Oncotarget 2016;7:72746-57. [PMID: 27322082 DOI: 10.18632/oncotarget.10125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
139 Zhan N, Michael AA, Wu K, Zeng G, Bell A, Tao J, Monga SP. The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model. Gene Expr 2018;18:135-47. [PMID: 29409568 DOI: 10.3727/105221618X15174108894682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
140 Muñoz-Moreno L, Arenas MI, Carmena MJ, Schally AV, Sánchez-Chapado M, Prieto JC, Bajo AM. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer. Oncotarget 2016;7:52195-206. [PMID: 27448980 DOI: 10.18632/oncotarget.10710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
141 Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G, Liang J. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep 2018;8:37. [PMID: 29311567 DOI: 10.1038/s41598-017-18280-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
142 Yong-Ming H, Ai-Jun J, Xiao-Yue X, Jian-Wei L, Chen Y, Ye C. miR-449a: a potential therapeutic agent for cancer. Anticancer Drugs 2017;28:1067-78. [PMID: 29023247 DOI: 10.1097/CAD.0000000000000555] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
143 Balázs M, Koroknai V, Szász I, Ecsedi S. Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization. Methods Mol Biol 2018;1726:85-100. [PMID: 29468546 DOI: 10.1007/978-1-4939-7565-5_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
144 Di Sante G, Casimiro MC, Li Z, Ertel A, Tompa P, Pestell RG. D-Type Cyclins and Gene Transcription. D-type Cyclins and Cancer 2018. [DOI: 10.1007/978-3-319-64451-6_3] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
145 de Brot S, Mongan NP. The Cell Cycle and Androgen Signaling Interactions in Prostate Cancer. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-64096-9_22] [Reference Citation Analysis]
146 Valenzuela C, Brown NE. Cyclin D1, Metabolism, and the Autophagy-Senescence Balance. D-type Cyclins and Cancer 2018. [DOI: 10.1007/978-3-319-64451-6_5] [Reference Citation Analysis]
147 Varland S, Myklebust LM, Goksøyr SØ, Glomnes N, Torsvik J, Varhaug JE, Arnesen T. Identification of an alternatively spliced nuclear isoform of human N-terminal acetyltransferase Naa30. Gene 2018;644:27-37. [PMID: 29247799 DOI: 10.1016/j.gene.2017.12.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
148 Huang J, Zheng C, Shao J, Chen L, Liu X, Shao J. Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway. Biochemical and Biophysical Research Communications 2017;494:542-9. [DOI: 10.1016/j.bbrc.2017.10.116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
149 Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Oncotarget 2016;7:19519-30. [PMID: 26799586 DOI: 10.18632/oncotarget.6961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
150 Hydbring P, Wang Y, Bogorad RL, Yin H, Anderson DG, Li C, Sicinski P. Identification of cell cycle-targeting microRNAs through genome-wide screens. Cell Cycle 2017;16:2241-8. [PMID: 29099267 DOI: 10.1080/15384101.2017.1380132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
151 Zhou W, Xu S, Ying Y, Zhou R, Chen X. Resveratrol Suppresses Growth and Migration of Myelodysplastic Cells by Inhibiting the Expression of Elevated Cyclin D1 ( CCND1 ). DNA and Cell Biology 2017;36:966-75. [DOI: 10.1089/dna.2017.3846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
152 Liao WT, You HL, Chai CY, Lee CH, Lan CE, Chang SJ, Yu CL, Yu HS. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease. J Dermatol Sci 2018;89:191-7. [PMID: 29103775 DOI: 10.1016/j.jdermsci.2017.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
153 Chen J, Li X, Cheng Q, Ning D, Ma J, Zhang Z, Chen X, Jiang L. Retracted : Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. J Cell Biochem 2018;119:2368-80. [DOI: 10.1002/jcb.26400] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
154 Mahjabeen S, Hatipoglu MK, Chandra V, Benbrook DM, Garcia-Contreras L. Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia. J Pharm Sci 2018;107:638-46. [PMID: 28989018 DOI: 10.1016/j.xphs.2017.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
155 Liu S, Wang J, Shao T, Song P, Kong Q, Hua H, Luo T, Jiang Y. The natural agent rhein induces β-catenin degradation and tumour growth arrest. J Cell Mol Med 2018;22:589-99. [PMID: 29024409 DOI: 10.1111/jcmm.13346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
156 Kang AR, An HT, Ko J, Choi EJ, Kang S. Ataxin-1 is involved in tumorigenesis of cervical cancer cells via the EGFR-RAS-MAPK signaling pathway. Oncotarget 2017;8:94606-18. [PMID: 29212253 DOI: 10.18632/oncotarget.21814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
157 Gumeni S, Evangelakou Z, Gorgoulis VG, Trougakos IP. Proteome Stability as a Key Factor of Genome Integrity. Int J Mol Sci 2017;18:E2036. [PMID: 28937603 DOI: 10.3390/ijms18102036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
158 Shen CQ, Yan TT, Liu W, Zhu XQ, Tian XL, Fu XL, Hua R, Zhang JF, Huo YM, Liu DJ, Yang JY, Sun YW, Fang JY, Chen HY, Hong J. High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation. J Cancer 2017;8:3154-65. [PMID: 29158787 DOI: 10.7150/jca.20086] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
159 Liu Y, Xu X, Xu X, Li S, Liang Z, Hu Z, Wu J, Zhu Y, Jin X, Wang X, Lin Y, Chen H, Mao Y, Luo J, Zheng X, Xie L. MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1. Oncol Lett 2017;14:5121-8. [PMID: 29142597 DOI: 10.3892/ol.2017.6865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
160 Xu M, Liu X, Xu Y, Zhu S, Gao Y. Co‑expression of Axin and APC gene fragments inhibits colorectal cancer cell growth via regulation of the Wnt signaling pathway. Mol Med Rep 2017;16:3783-90. [PMID: 28731177 DOI: 10.3892/mmr.2017.7049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
161 Di Sante G, Di Rocco A, Pupo C, Casimiro MC, Pestell RG. Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer. Oncotarget 2017;8:81803-12. [PMID: 29137223 DOI: 10.18632/oncotarget.19413] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
162 Velu P, Vinothkumar V, Babukumar S, Ramachandhiran D. Chemopreventive effect of syringic acid on 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. Toxicology Mechanisms and Methods 2017;27:631-40. [DOI: 10.1080/15376516.2017.1349227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
163 Do DN, Dudemaine PL, Li R, Ibeagha-Awemu EM. Co-Expression Network and Pathway Analyses Reveal Important Modules of miRNAs Regulating Milk Yield and Component Traits. Int J Mol Sci 2017;18:E1560. [PMID: 28718798 DOI: 10.3390/ijms18071560] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
164 Subbiah IM, Tsimberidou A, Subbiah V, Janku F, Roy-Chowdhuri S, Hong DS. Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape. Oncoscience 2017;4:47-56. [PMID: 28781987 DOI: 10.18632/oncoscience.352] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
165 Attarwala H, Han M, Kim J, Amiji M. Oral nucleic acid therapy using multicompartmental delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2018;10. [PMID: 28544521 DOI: 10.1002/wnan.1478] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
166 Casimiro MC, Di Sante G, Di Rocco A, Loro E, Pupo C, Pestell TG, Bisetto S, Velasco-Velázquez MA, Jiao X, Li Z, Kusminski CM, Seifert EL, Wang C, Ly D, Zheng B, Shen CH, Scherer PE, Pestell RG. Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis. Cancer Res 2017;77:3391-405. [PMID: 28522753 DOI: 10.1158/0008-5472.CAN-16-0425] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
167 Hu C, Lv L, Peng J, Liu D, Wang X, Zhou Y, Huo J. MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression. Oncol Lett 2017;13:4769-75. [PMID: 28599478 DOI: 10.3892/ol.2017.6098] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
168 Bailey KL, Agarwal E, Chowdhury S, Luo J, Brattain MG, Black JD, Wang J. TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells. PLoS One 2017;12:e0176096. [PMID: 28414818 DOI: 10.1371/journal.pone.0176096] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
169 Yoshimoto T, Tanaka M, Homme M, Yamazaki Y, Takazawa Y, Antonescu CR, Nakamura T. CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma. Cancer Res 2017;77:2927-37. [PMID: 28404587 DOI: 10.1158/0008-5472.CAN-16-3351] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 9.3] [Reference Citation Analysis]
170 Aqil F, Jeyabalan J, Munagala R, Ravoori S, Vadhanam MV, Schultz DJ, Gupta RC. Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices. Int J Mol Sci 2017;18:E425. [PMID: 28212313 DOI: 10.3390/ijms18020425] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
171 Zhang B, Han S, Feng B, Chu X, Chen L, Wang R. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Exp Mol Med. 2017;49:e293. [PMID: 28186085 DOI: 10.1038/emm.2016.177] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
172 Wang M, Wu J, Guo Y, Chang X, Cheng T. The tripartite motif-containing protein 3 on the proliferation and cytokine secretion of rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep 2017;15:1607-12. [PMID: 28259936 DOI: 10.3892/mmr.2017.6164] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
173 Yang N, Yao N, Liao X, Xie X, Wu Y, Fan C, Zhao J, Li G. Effects of metal ions on the structure and activity of a human anti-cyclin D1 single-chain variable fragment AD5. Molecular Medicine Reports 2017;16:1314-1320. [DOI: 10.3892/mmr.2017.6756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
174 Ying S, Du X, Fu W, Yun D, Chen L, Cai Y, Xu Q, Wu J, Li W, Liang G. Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer. European Journal of Medicinal Chemistry 2017;127:885-99. [DOI: 10.1016/j.ejmech.2016.10.066] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
175 Casimiro MC, Pestell RG, Knudsen ES. Cell Cycle-Related Kinases. Cancer Therapeutic Targets 2017. [DOI: 10.1007/978-1-4419-0717-2_13] [Reference Citation Analysis]
176 Gowda R, Kardos G, Sharma A, Singh S, Robertson GP. Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma. Mol Cancer Ther 2017;16:440-52. [PMID: 28003325 DOI: 10.1158/1535-7163.MCT-16-0285] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
177 Marampon F, Gravina G, Ju X, Vetuschi A, Sferra R, Casimiro M, Pompili S, Festuccia C, Colapietro A, Gaudio E, Di Cesare E, Tombolini V, Pestell RG. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage. Oncotarget 2016;7:5383-400. [PMID: 26689991 DOI: 10.18632/oncotarget.6579] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
178 Lin Z, Sheng H, You C, Cai M, Zhang Y, Yu LS, Yu X, Lin J, Zhang N. Inhibition of the CyclinD1 promoter in response to sonic hedgehog signaling pathway transduction is mediated by Gli1. Exp Ther Med 2017;13:307-14. [PMID: 28123507 DOI: 10.3892/etm.2016.3969] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
179 Kafri P, Hasenson SE, Kanter I, Sheinberger J, Kinor N, Yunger S, Shav-Tal Y. Quantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cells. Elife 2016;5:e16748. [PMID: 27879202 DOI: 10.7554/eLife.16748] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
180 Wang N, Wang X, Tan HY, Li S, Tsang CM, Tsao SW, Feng Y. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells. Int J Mol Sci 2016;17:E1899. [PMID: 27854312 DOI: 10.3390/ijms17111899] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
181 Magro G, Salvatorelli L, Alaggio R, D'Agata V, Nicoletti F, Di Cataldo A, Parenti R. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents. Hum Pathol 2017;60:58-65. [PMID: 27984122 DOI: 10.1016/j.humpath.2016.07.038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
182 Xu S, Yi XM, Zhang ZY, Ge JP, Zhou WQ. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma. Mol Med Rep 2016;14:5025-32. [PMID: 27779679 DOI: 10.3892/mmr.2016.5859] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
183 Park GH, Sung JH, Song HM, Jeong JB. Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells. BMC Complement Altern Med 2016;16:373. [PMID: 27670681 DOI: 10.1186/s12906-016-1364-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
184 Ribeiro MP, Custódio JB, Santos AE. Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? Cancer Chemother Pharmacol 2017;79:219-25. [PMID: 27586965 DOI: 10.1007/s00280-016-3129-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
185 Tadesse S, Yu M, Kumarasiri M, Le BT, Wang S. Targeting CDK6 in cancer: State of the art and new insights. Cell Cycle 2015;14:3220-30. [PMID: 26315616 DOI: 10.1080/15384101.2015.1084445] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 11.1] [Reference Citation Analysis]
186 Liu YC, Lee CY, Lin CL, Chen HY, Liu GY, Hung HC. Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor. Oncotarget 2015;6:23917-29. [PMID: 26172301 DOI: 10.18632/oncotarget.4469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
187 Roque Cuéllar MC, García-Lozano JR, Sánchez B, Praena-Fernández JM, Martínez Sierra C, Núñez-Roldán A, Aguilar-Reina J. Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infection. J Viral Hepat 2016;23:606-13. [PMID: 26946048 DOI: 10.1111/jvh.12526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
188 Kenyon EJ, Luijten MN, Gill H, Li N, Rawlings M, Bull JC, Hadzhiev Y, van Steensel MA, Maher E, Mueller F. Expression and knockdown of zebrafish folliculin suggests requirement for embryonic brain morphogenesis. BMC Dev Biol 2016;16:23. [PMID: 27391801 DOI: 10.1186/s12861-016-0119-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
189 Attarwala H, Amiji M. Biodegradable Polyester-Based Multi-Compartmental Delivery Systems for Oral Nucleic Acid Therapy. Handbook of Polyester Drug Delivery Systems 2016. [DOI: 10.1201/b20045-14] [Reference Citation Analysis]
190 Schaeffer E, Vigneron M, Sibler AP, Oulad-Abdelghani M, Chatton B, Donzeau M. ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression. Cell Cycle 2015;14:2655-66. [PMID: 26101806 DOI: 10.1080/15384101.2015.1064568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
191 Chaves-Ferreira M, Krenn G, Vasseur F, Barinov A, Gonçalves P, Azogui O, Cumano A, Li Z, Pellegrini S, Rocha B, Laderach D. The cyclin D1 carboxyl regulatory domain controls the division and differentiation of hematopoietic cells. Biol Direct 2016;11:21. [PMID: 27129404 DOI: 10.1186/s13062-016-0122-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
192 Bendris N, Lemmers B, Blanchard JM. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors. Cell Cycle. 2015;14:1786-1798. [PMID: 25789852 DOI: 10.1080/15384101.2014.998085] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 15.4] [Reference Citation Analysis]
193 Zhou L, Yang K, Randall Wickett R, Zhang Y. Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development. Cancer Med 2016;5:1566-79. [PMID: 27061029 DOI: 10.1002/cam4.707] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
194 Samatiwat P, Prawan A, Senggunprai L, Kukongviriyapan U, Kukongviriyapan V. Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. Tumor Biol 2016;37:11495-507. [DOI: 10.1007/s13277-016-5015-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
195 Sukamporn P, Rojanapanthu P, Silva G, Zhang X, Gritsanapan W, Baek SJ. Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation. Life Sci 2016;152:60-6. [PMID: 27018445 DOI: 10.1016/j.lfs.2016.03.038] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
196 Han K, Chen X, Bian N, Ma B, Yang T, Cai C, Fan Q, Zhou Y, Zhao TB. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1. Oncotarget 2015;6:8875-89. [PMID: 25823925 DOI: 10.18632/oncotarget.3560] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
197 Jin Y, Dai Z. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells. Biomedicine & Pharmacotherapy 2016;78:264-71. [DOI: 10.1016/j.biopha.2016.01.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
198 Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget 2015;6:9160-72. [PMID: 25863539 DOI: 10.18632/oncotarget.3247] [Cited by in Crossref: 104] [Cited by in F6Publishing: 125] [Article Influence: 14.9] [Reference Citation Analysis]
199 Lanza DG, Dawson EP, Rao P, Heaney JD. Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation. Cell Cycle 2016;15:919-30. [PMID: 26901436 DOI: 10.1080/15384101.2016.1149272] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
200 Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, Tozeren A, Knudsen ES, Arnold A, Pestell RG. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget 2015;6:8525-38. [PMID: 25940700 DOI: 10.18632/oncotarget.3267] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
201 Fleischmann KK, Pagel P, von Frowein J, Magg T, Roscher AA, Schmid I. The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression. J Exp Clin Cancer Res 2016;35:9. [PMID: 26762252 DOI: 10.1186/s13046-016-0283-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
202 Casimiro MC, Pestell RG, Knudsen ES. Cell Cycle-Related Kinases. Cancer Therapeutic Targets 2016. [DOI: 10.1007/978-1-4614-6613-0_13-5] [Reference Citation Analysis]
203 Salajegheh A. Cyclin D1 and E1. Angiogenesis in Health, Disease and Malignancy 2016. [DOI: 10.1007/978-3-319-28140-7_7] [Reference Citation Analysis]
204 Sato-Kuwabara Y, Fregnani JH, Jampietro J, Carvalho KC, Franco CP, da Costa WL Jr, Coimbra FJ, Soares FA. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. Tumour Biol 2016;37:6691-9. [PMID: 26649862 DOI: 10.1007/s13277-015-4551-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
205 Mohan A, Narayanan S, Balasubramanian G, Sethuraman S, Krishnan UM. Dual drug loaded nanoliposomal chemotherapy: A promising strategy for treatment of head and neck squamous cell carcinoma. Eur J Pharm Biopharm 2016;99:73-83. [PMID: 26690333 DOI: 10.1016/j.ejpb.2015.11.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
206 Sundar R, Gudey SK, Heldin CH, Landström M. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor. Cell Cycle 2015;14:554-65. [PMID: 25622187 DOI: 10.4161/15384101.2014.990302] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
207 Parandin R, Behnam Rassouli M, Sisakhtnezhad S, Mahdavi Shahri N. In Vitro Evaluation of the Effects of Zearalenone and α-Zearalenol on MCF-7 and MDA-MB-468 Cell Lines of Human Breast Cancer. Razavi Int J Med 2015;3. [DOI: 10.17795/rijm30231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
208 Casimiro MC, Di Sante G, Ju X, Li Z, Chen K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, Pestell RG. Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells. Cancer Res 2016;76:329-38. [PMID: 26582866 DOI: 10.1158/0008-5472.CAN-15-0999] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
209 Azmahani A, Nakamura Y, Ozawa Y, Mcnamara KM, Fujimura T, Haga T, Hashimoto A, Aiba S, Sasano H. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease. Human Pathology 2015;46:1662-9. [DOI: 10.1016/j.humpath.2015.07.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
210 Oladimeji P, Kubohara Y, Kikuchi H, Oshima Y, Rusch C, Skerl R, Diakonova M. A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1 Activity and Breast Cancer Cell Proliferation. Int J Cancer Clin Res 2015;2:1-6. [PMID: 26688830 DOI: 10.23937/2378-3419/2/4/1023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
211 Tigan AS, Bellutti F, Kollmann K, Tebb G, Sexl V. CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation. Oncogene 2016;35:3083-91. [PMID: 26500059 DOI: 10.1038/onc.2015.407] [Cited by in Crossref: 92] [Cited by in F6Publishing: 101] [Article Influence: 11.5] [Reference Citation Analysis]
212 Hadjimichael C, Chanoumidou K, Papadopoulou N, Arampatzi P, Papamatheakis J, Kretsovali A. Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells 2015;7:1150-84. [PMID: 26516408 DOI: 10.4252/wjsc.v7.i9.1150] [Cited by in F6Publishing: 108] [Reference Citation Analysis]
213 Schröder A, Rohrbeck A, Just I, Pich A. Proteome Alterations of Hippocampal Cells Caused by Clostridium botulinum C3 Exoenzyme. J Proteome Res 2015;14:4721-33. [PMID: 26393427 DOI: 10.1021/acs.jproteome.5b00591] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
214 Bagci O, Kurtgöz S. Amplification of Cellular Oncogenes in Solid Tumors. N Am J Med Sci 2015;7:341-6. [PMID: 26417556 DOI: 10.4103/1947-2714.163641] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
215 Willson CJ, Flake GP, Sills RC, Kissling GE, Cesta MF. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats. Vet Pathol 2016;53:682-90. [PMID: 26319780 DOI: 10.1177/0300985815603432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
216 Messina S, Bitto A, Vita GL, Aguennouz M, Irrera N, Licata N, Sframeli M, Bruschetta D, Minutoli L, Altavilla D, Vita G, Squadrito F. Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice. Biofactors 2015;41:324-9. [PMID: 26332024 DOI: 10.1002/biof.1226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
217 Jirawatnotai S, Sharma S, Michowski W, Suktitipat B, Geng Y, Quackenbush J, Elias JE, Gygi SP, Wang YE, Sicinski P. The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis. Cell Cycle 2014;13:2889-900. [PMID: 25486477 DOI: 10.4161/15384101.2014.946850] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
218 Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ. De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer. Pharmacogenomics 2015;16:1411-26. [PMID: 26257318 DOI: 10.2217/pgs.15.88] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
219 Sun R, Zhang J, Xiong M, Wei H, Tan K, Yin L, Pu Y. Altered Expression of Genes in Signaling Pathways Regulating Proliferation of Hematopoietic Stem and Progenitor Cells in Mice with Subchronic Benzene Exposure. Int J Environ Res Public Health 2015;12:9298-313. [PMID: 26262635 DOI: 10.3390/ijerph120809298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
220 Grewal R, Cucuianu A, Swanepoel C, Dima D, Petrushev B, Pop B, Berindan-Neagoe I, Abayomi EA, Tomuleasa C. The role of microRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci 2015;52:232-41. [PMID: 26218036 DOI: 10.3109/10408363.2015.1030063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
221 Xu Y, Zhang J, Jiang W, Zhang S. Astaxanthin induces angiogenesis through Wnt/β-catenin signaling pathway. Phytomedicine 2015;22:744-51. [DOI: 10.1016/j.phymed.2015.05.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
222 Sun G, Cao Y, Shi L, Sun L, Wang Y, Chen C, Wan Z, Fu L, You Y. Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. Cancer Biother Radiopharm 2013;28:327-34. [PMID: 25310349 DOI: 10.1089/cbr.2012.1380] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
223 Studer P, da Silva CG, Revuelta Cervantes JM, Mele A, Csizmadia E, Siracuse JJ, Damrauer SM, Peterson CR, Candinas D, Stroka DM, Ma A, Bhasin M, Ferran C. Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration. Cell Death Differ 2015;22:2068-77. [PMID: 25976305 DOI: 10.1038/cdd.2015.52] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
224 De Leonardis F, Monti L, Gualeni B, Tenni R, Forlino A, Rossi A. Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. J Cell Biochem 2014;115:1779-86. [PMID: 24820054 DOI: 10.1002/jcb.24844] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
225 Mahale S, Bharate SB, Manda S, Joshi P, Jenkins PR, Vishwakarma RA, Chaudhuri B. Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization. Cell Death Dis 2015;6:e1743. [PMID: 25950473 DOI: 10.1038/cddis.2015.96] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
226 de Andrade FG, Marie SK, Uno M, Matushita H, Taricco MA, Teixeira MJ, Rosemberg S, Oba-Shinjo SM. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases. Neuropathology 2015;35:312-23. [PMID: 25946121 DOI: 10.1111/neup.12195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
227 Gavilán E, Giráldez S, Sánchez-Aguayo I, Romero F, Ruano D, Daza P. Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3β dependent mechanism. Sci Rep 2015;5:10027. [PMID: 25941117 DOI: 10.1038/srep10027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
228 Magro G, Salvatorelli L, Di Cataldo A, Musumeci G, Spoto G, Parenti R. Cyclin D1 in human neuroblastic tumors recapitulates its developmental expression: An immunohistochemical study. Acta Histochem 2015;117:415-24. [PMID: 25765113 DOI: 10.1016/j.acthis.2015.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
229 Lee J, Chung L, Chen Y, Feng T, Chen W, Juang H. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells. Cancer Letters 2015;360:310-8. [DOI: 10.1016/j.canlet.2015.02.034] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
230 Magro G, Brancato F, Musumeci G, Alaggio R, Parenti R, Salvatorelli L. Cyclin D1 is a useful marker for soft tissue Ewing's sarcoma/peripheral Primitive Neuroectodermal Tumor in children and adolescents: A comparative immunohistochemical study with rhabdomyosarcoma. Acta Histochem 2015;117:460-7. [PMID: 25765111 DOI: 10.1016/j.acthis.2015.01.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
231 Menezes ME, Das SK, Emdad L, Windle JJ, Wang XY, Sarkar D, Fisher PB. Genetically engineered mice as experimental tools to dissect the critical events in breast cancer. Adv Cancer Res 2014;121:331-82. [PMID: 24889535 DOI: 10.1016/B978-0-12-800249-0.00008-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
232 Hu G, Yang T, Zheng J, Dai J, Nan A, Lai Y, Zhang Y, Yang C, Jiang Y. Functional role and mechanism of lncRNA LOC728228 in malignant 16HBE cells transformed by anti-benzopyrene-trans-7,8-dihydrodiol-9,10-epoxide. Mol Carcinog 2015;54 Suppl 1:E192-204. [PMID: 25820656 DOI: 10.1002/mc.22314] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
233 Kubokura N, Takahashi-Yanaga F, Arioka M, Yoshihara T, Igawa K, Tomooka K, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Matsumoto T, Kitazono T, Sasaguri T. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo. J Pharmacol Sci 2015;127:446-55. [PMID: 25913757 DOI: 10.1016/j.jphs.2015.03.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
234 Yousfi N, Pruvot B, Lopez T, Magadoux L, Franche N, Pichon L, Salvadori F, Solary E, Garrido C, Laurens V, Chluba J. The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft model. PLoS One 2015;10:e0120435. [PMID: 25768009 DOI: 10.1371/journal.pone.0120435] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
235 Chen K, Gao Q, Zhang W, Liu Z, Cai J, Liu Y, Xu J, Li J, Yang Y, Xu X. Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway. Liver Int 2015;35:986-98. [PMID: 24444033 DOI: 10.1111/liv.12458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
236 Zhou C, Zhang P, Xu GC, Wu DM, Liu RY, Zeng Q, Wang CT. RNA interference of Biot2 induces G1 phase arrest and apoptosis in mouse colorectal cancer cell line. Oncol Res 2015;22:93-103. [PMID: 25706396 DOI: 10.3727/096504014X14146137738583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Zhou SJ, Li M, Zeng DX, Zhu ZM, Hu XW, Li YH, Wang R, Sun GY. Expression variations of connective tissue growth factor in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease. Sci Rep 2015;5:8564. [PMID: 25708588 DOI: 10.1038/srep08564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
238 Mauro L, Pellegrino M, Giordano F, Ricchio E, Rizza P, De Amicis F, Catalano S, Bonofiglio D, Panno ML, Andò S. Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells. FASEB J 2015;29:2150-60. [PMID: 25657113 DOI: 10.1096/fj.14-262808] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
239 Wang K, Yan R, Cooper KF, Strich R. Cyclin C mediates stress-induced mitochondrial fission and apoptosis. Mol Biol Cell 2015;26:1030-43. [PMID: 25609094 DOI: 10.1091/mbc.E14-08-1315] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
240 Wei WY, Yan LH, Wang XT, Li L, Cao WL, Zhang XS, Zhan ZX, Yu H, Xie YB, Xiao Q. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivoWorld J Gastroenterol 2015; 21(2): 491-501 [PMID: 25593464 DOI: 10.3748/wjg.v21.i2.491] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
241 Bizen N, Inoue T, Shimizu T, Tabu K, Kagawa T, Taga T. A growth-promoting signaling component cyclin D1 in neural stem cells has antiastrogliogenic function to execute self-renewal. Stem Cells 2014;32:1602-15. [PMID: 24302516 DOI: 10.1002/stem.1613] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
242 Casimiro MC, Pestell RG, Knudsen ES. Cell Cycle Related Kinases. Cancer Therapeutic Targets 2015. [DOI: 10.1007/978-1-4614-6613-0_13-4] [Reference Citation Analysis]
243 Liang Z, Li S, Xu X, Xu X, Wang X, Wu J, Zhu Y, Hu Z, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1. Mol Cells 2015;38:130-7. [PMID: 25556372 DOI: 10.14348/molcells.2015.2146] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
244 Parenti R, Cardile V, Graziano AC, Parenti C, Venuti A, Bertuccio MP, Furno DL, Magro G. Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line. PLoS One 2014;9:e114333. [PMID: 25474318 DOI: 10.1371/journal.pone.0114333] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
245 Nery LR, Eltz NS, Martins L, Guerim LD, Pereira TC, Bogo MR, Vianna MR. Sustained behavioral effects of lithium exposure during early development in zebrafish: involvement of the Wnt-β-catenin signaling pathway. Prog Neuropsychopharmacol Biol Psychiatry 2014;55:101-8. [PMID: 24813569 DOI: 10.1016/j.pnpbp.2014.04.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
246 Dumitrescu A, Aberdeen GW, Pepe GJ, Albrecht ED. Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex. Endocrinology 2014;155:4774-84. [PMID: 25247468 DOI: 10.1210/en.2014-1221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
247 Wu F, Luo L, Liu Y, Zhan Q, Luo C, Luo J, Zhang G, Feng Z. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells. Cancer Letters 2014;355:159-67. [DOI: 10.1016/j.canlet.2014.08.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
248 Mahoney S, Arfuso F, Millward M, Dharmarajan A. The effects of phenoxodiol on the cell cycle of prostate cancer cell lines. Cancer Cell Int 2014;14:110. [PMID: 25400509 DOI: 10.1186/s12935-014-0110-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
249 Shuai S, Yan X, Zhang J, Kang S, Chen F, Luo R, Li A. TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma. Cancer Letters 2014;354:200-9. [DOI: 10.1016/j.canlet.2014.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
250 Bhalla K, Liu WJ, Thompson K, Anders L, Devarakonda S, Dewi R, Buckley S, Hwang BJ, Polster B, Dorsey SG, Sun Y, Sicinski P, Girnun GD. Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1α. Diabetes 2014;63:3266-78. [PMID: 24947365 DOI: 10.2337/db13-1283] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
251 Yadav VR, Sahoo K, Awasthi V. Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. Br J Pharmacol 2013;170:1436-48. [PMID: 24102070 DOI: 10.1111/bph.12406] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
252 Liu LC, Su CH, Wang HC, Chang WS, Tsai CW, Maa MC, Tsai CH, Tsai FJ, Bau DT. Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk. Biomedicine (Taipei) 2014;4:3. [PMID: 25520916 DOI: 10.7603/s40681-014-0003-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
253 Cao H, Luo S, Xu M, Zhang Y, Song S, Wang S, Kong X, He N, Cao X, Yan F, Wang B. The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apc min/+ mice through enhancing Wnt signaling. Familial Cancer 2014;13:563-71. [DOI: 10.1007/s10689-014-9742-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
254 Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R. Algorithms to model single gene, single chromosome, and whole genome copy number changes jointly in tumor phylogenetics. PLoS Comput Biol 2014;10:e1003740. [PMID: 25078894 DOI: 10.1371/journal.pcbi.1003740] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
255 Brennan KM, Samuel RS, Graugnard TA, Xiao R, Cantor AH, Pescatore AJ. Organic trace mineral levels in the first 96-h post-hatch impact growth performance and intestinal gene expression in broiler chicks. Biol Trace Elem Res 2013;156:166-74. [PMID: 24078312 DOI: 10.1007/s12011-013-9813-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
256 Yu Z, Wang L, Wang C, Ju X, Wang M, Chen K, Loro E, Li Z, Zhang Y, Wu K, Casimiro MC, Gormley M, Ertel A, Fortina P, Chen Y, Tozeren A, Liu Z, Pestell RG. Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer. Nat Commun 2013;4:2812. [PMID: 24287487 DOI: 10.1038/ncomms3812] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
257 Wu W, Yang L, Chen H. Effects of konjac glucomannan, inulin and cellulose on acute colonic responses to genotoxic azoxymethane. Food Chemistry 2014;155:304-10. [DOI: 10.1016/j.foodchem.2014.01.065] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
258 Gurgel CA, Buim ME, Carvalho KC, Sales CB, Reis MG, de Souza RO, de Faro Valverde L, de Azevedo RA, Dos Santos JN, Soares FA, Ramos EA. Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma. J Oral Pathol Med 2014;43:619-26. [PMID: 24930892 DOI: 10.1111/jop.12180] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
259 Fu J, Tian C, Xing M, Wang X, Guo H, Sun L, Sun L, Jiang Z, Zhang L. KU004 induces G1 cell cycle arrest in human breast cancer SKBR-3 cells by modulating PI3K/Akt pathway. Biomed Pharmacother. 2014;68:625-630. [PMID: 24996960 DOI: 10.1016/j.biopha.2014.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
260 Pysz MA, Hao F, Hizli AA, Lum MA, Swetzig WM, Black AR, Black JD. Differential regulation of cyclin D1 expression by protein kinase C α and ϵ signaling in intestinal epithelial cells. J Biol Chem 2014;289:22268-83. [PMID: 24914206 DOI: 10.1074/jbc.M114.571554] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
261 Dabydeen SA, Furth PA. Genetically engineered ERα-positive breast cancer mouse models. Endocr Relat Cancer 2014;21:R195-208. [PMID: 24481326 DOI: 10.1530/ERC-13-0512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
262 Sama RR, Ward CL, Bosco DA. Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro 2014;6:1759091414544472. [PMID: 25289647 DOI: 10.1177/1759091414544472] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
263 Vallejo G, La Greca AD, Tarifa-Reischle IC, Mestre-Citrinovitz AC, Ballaré C, Beato M, Saragüeta P. CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. PLoS One 2014;9:e97311. [PMID: 24859236 DOI: 10.1371/journal.pone.0097311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
264 Jia Y, Domenico J, Swasey C, Wang M, Gelfand EW, Lucas JJ. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. PLoS One. 2014;9:e97448. [PMID: 24848372 DOI: 10.1371/journal.pone.0097448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
265 Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, Liu YW, Zhang EB, Liu XH, De W. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319. [PMID: 24884417 DOI: 10.1186/1471-2407-14-319] [Cited by in Crossref: 216] [Cited by in F6Publishing: 244] [Article Influence: 24.0] [Reference Citation Analysis]
266 Suga A, Sadamoto K, Fujii M, Mandai M, Takahashi M. Proliferation potential of Müller glia after retinal damage varies between mouse strains. PLoS One 2014;9:e94556. [PMID: 24747725 DOI: 10.1371/journal.pone.0094556] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
267 Takahashi-Yanaga F, Yoshihara T, Jingushi K, Igawa K, Tomooka K, Watanabe Y, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Sasaguri T. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice. Biochem Pharmacol 2014;89:340-8. [PMID: 24670930 DOI: 10.1016/j.bcp.2014.03.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
268 Barilli A, Atzeri C, Bassanetti I, Ingoglia F, Dall'Asta V, Bussolati O, Maffini M, Mucchino C, Marchiò L. Oxidative stress induced by copper and iron complexes with 8-hydroxyquinoline derivatives causes paraptotic death of HeLa cancer cells. Mol Pharm 2014;11:1151-63. [PMID: 24592930 DOI: 10.1021/mp400592n] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 7.6] [Reference Citation Analysis]
269 Hamid SM, Cicek S, Karamil S, Ozturk MB, Debelec-Butuner B, Erbaykent-Tepedelen B, Varisli L, Gonen-Korkmaz C, Yorukoglu K, Korkmaz KS. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate. Mol Cell Endocrinol 2014;383:38-47. [PMID: 24325868 DOI: 10.1016/j.mce.2013.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
270 Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Mol Endocrinol 2014;28:442-57. [PMID: 24606123 DOI: 10.1210/me.2013-1196] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
271 Saglam O, Dai F, Husain S, Zhan Y, Toruner G, Haines GK 3rd. Matricellular protein CCN1 (CYR61) expression is associated with high-grade ductal carcinoma in situ. Hum Pathol 2014;45:1269-75. [PMID: 24767859 DOI: 10.1016/j.humpath.2014.02.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
272 Dai X, Cai C, Xiao F, Xiong Y, Huang Y, Zhang Q, Xiang Q, Lou G, Lian M, Su Z, Zheng Q. Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library. Biochem Biophys Res Commun 2014;445:795-801. [PMID: 24530908 DOI: 10.1016/j.bbrc.2014.02.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
273 Wang H, Jia XZ, Sui CJ, Zhao YP, Mei YF, Zheng YN, Zhang ZY. Effects of thapsigargin on the proliferation and survival of human rheumatoid arthritis synovial cells. ScientificWorldJournal 2014;2014:605416. [PMID: 24688409 DOI: 10.1155/2014/605416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
274 Raynaud C, Mallory AC, Latrasse D, Jégu T, Bruggeman Q, Delarue M, Bergounioux C, Benhamed M. Chromatin meets the cell cycle. Journal of Experimental Botany 2014;65:2677-89. [DOI: 10.1093/jxb/ert433] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
275 Hu J, Fang Y, Cao Y, Qin R, Chen Q. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci 2014;59:336-45. [PMID: 24248414 DOI: 10.1007/s10620-013-2923-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
276 Hussain I, Husain Q, Baredes S, Eloy JA, Jyung RW, Liu JK. Molecular genetics of paragangliomas of the skull base and head and neck region: implications for medical and surgical management: A review. JNS 2014;120:321-30. [DOI: 10.3171/2013.10.jns13659] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
277 Zhang Q, Sakamoto K, Wagner KU. D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells. Mol Cell Endocrinol 2014;382:583-92. [PMID: 23562856 DOI: 10.1016/j.mce.2013.03.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
278 Bradley BS, Loftus JC, Mielke CJ, Dinu V. Differential expression of microRNAs as predictors of glioblastoma phenotypes. BMC Bioinformatics 2014;15:21. [PMID: 24438171 DOI: 10.1186/1471-2105-15-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
279 Guo R. Biology of Melanoma. The Melanocytic Proliferations 2014. [DOI: 10.1002/9781118488935.ch13] [Reference Citation Analysis]
280 Gu H, Yang T, Fu S, Chen X, Guo L, Ni Y. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Biochem Biophys Res Commun. 2014;444:104-108. [PMID: 24440705 DOI: 10.1016/j.bbrc.2014.01.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
281 Pang X, Shu Y, Niu Z, Zheng W, Wu H, Lu Y, Shen P. PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells. Exp Cell Res 2014;322:30-8. [PMID: 24440556 DOI: 10.1016/j.yexcr.2014.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
282 Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila) 2014;7:300-9. [PMID: 24431404 DOI: 10.1158/1940-6207.CAPR-13-0345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
283 Gharibi B, Ghuman MS, Hughes FJ. Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal. J Cell Mol Med 2012;16:2789-801. [PMID: 22805337 DOI: 10.1111/j.1582-4934.2012.01602.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 8.9] [Reference Citation Analysis]
284 Ji C. New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. Int J Hepatol 2014;2014:513787. [PMID: 24868470 DOI: 10.1155/2014/513787] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
285 Esakky P, Hansen DA, Drury AM, Moley KH. Modulation of Cell Cycle Progression in the Spermatocyte Cell Line [GC-2spd(ts) Cell-Line] by Cigarette Smoke Condensate (CSC) via Arylhydrocarbon Receptor-Nuclear Factor Erythroid 2-Related Factor 2 (Ahr-Nrf2) Pathway1. Biology of Reproduction 2014;90. [DOI: 10.1095/biolreprod.113.113225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
286 Li C, Yan H, Fu H, Xu G, Wang X. Molecular cloning, sequence analysis, and function of the intestinal epithelial stem cell marker Bmi1 in pig intestinal epithelial cells1. Journal of Animal Science 2014;92:85-94. [DOI: 10.2527/jas.2013-7048] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
287 Fend F, Quintanilla-martínez L. Mantle Cell Lymphoma. Pathobiology of Human Disease 2014. [DOI: 10.1016/b978-0-12-386456-7.04107-1] [Reference Citation Analysis]
288 Grillo L, Greco D, Pettinato R, Avola E, Potenza N, Castiglia L, Spalletta A, Amata S, Di Benedetto D, Luciano D, Romano C, Fichera M. Increased FGF3 and FGF4 gene dosage is a risk factor for craniosynostosis. Gene 2014;534:435-9. [DOI: 10.1016/j.gene.2013.09.120] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
289 Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod Pathol 2014;27:87-95. [PMID: 23887292 DOI: 10.1038/modpathol.2013.125] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
290 Tomblin JK, Salisbury TB. Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 2014;443:1092-6. [PMID: 24380854 DOI: 10.1016/j.bbrc.2013.12.112] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
291 Apte SA, Cavazos DA, Whelan KA, Degraffenried LA. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer. Nutr Cancer 2013;65:556-62. [PMID: 23659447 DOI: 10.1080/01635581.2013.775316] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
292 Wang C, Zhang X, Tian L, Pestell RG. Emerging roles of peroxisome proliferator-activated receptor gamma in cancer. Molecular Oncology 2013. [DOI: 10.1017/cbo9781139046947.034] [Reference Citation Analysis]
293 Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R. Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations. Bioinformatics 2013;29:i189-98. [PMID: 23812984 DOI: 10.1093/bioinformatics/btt205] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
294 Zhong J, Cao R, Liu J, Liu Y, Wang J, Liu L, Chen Y, Yang J, Zhang Q, Wu Y, Ding W, Hong T, Xiao X, Zu X, Wen G. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein. Oncogene 2014;33:5546-58. [DOI: 10.1038/onc.2013.500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
295 Aref S, Mabed M, El-sherbiny M, Selim T, Metwaly A. Cyclin D1 expression in acute leukemia. Hematology 2013;11:31-4. [DOI: 10.1080/10245330500322321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
296 Cao H, Song S, Zhang H, Zhang Y, Qu R, Yang B, Jing Y, Hu T, Yan F, Wang B. Chemopreventive effects of berberine on intestinal tumor development in Apcmin/+ mice. BMC Gastroenterol 2013;13:163. [PMID: 24279644 DOI: 10.1186/1471-230X-13-163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
297 Ju X, Casimiro MC, Gormley M, Meng H, Jiao X, Katiyar S, Crosariol M, Chen K, Wang M, Quong AA. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint. Cancer Res. 2014;74:508-519. [PMID: 24282282 DOI: 10.1158/0008-5472.can-13-1313] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
298 Bologna-Molina R, Bedoya-Borella AM, Soria-Moreira L, Soría-Suárez S. Molecular biomarkers of cell proliferation in ameloblastomas. World J Stomatol 2013; 2(4): 79-85 [DOI: 10.5321/wjs.v2.i4.79] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
299 De Amicis F, Perri A, Vizza D, Russo A, Panno ML, Bonofiglio D, Giordano C, Mauro L, Aquila S, Tramontano D, Andò S. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J Cell Physiol 2013;228:2054-62. [PMID: 23553645 DOI: 10.1002/jcp.24372] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
300 Liu W, Ren H, Ren J, Yin T, Hu B, Xie S, Dai Y, Wu W, Xiao Z, Yang X, Xie D. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Mediators Inflamm 2013;2013:651207. [PMID: 24311896 DOI: 10.1155/2013/651207] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
301 Vizza D, Perri A, Lofaro D, Toteda G, Lupinacci S, Leone F, Gigliotti P, Papalia T, Bonofiglio R. Exposure to nerve growth factor worsens nephrotoxic effect induced by Cyclosporine A in HK-2 cells. PLoS One 2013;8:e80113. [PMID: 24244623 DOI: 10.1371/journal.pone.0080113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
302 Rana S, Munawar M, Shahid A, Malik M, Ullah H, Fatima W, Mohsin S, Mahmood S. Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep 2014;41:95-103. [DOI: 10.1007/s11033-013-2841-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
303 Oommen D, Prise KM. Down-regulation of PERK enhances resistance to ionizing radiation. Biochemical and Biophysical Research Communications 2013;441:31-5. [DOI: 10.1016/j.bbrc.2013.09.129] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
304 Martin A, Jones A, Bryar PJ, Mets M, Weinstein J, Zhang G, Laurie NA. MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastoma. Biochemical and Biophysical Research Communications 2013;440:599-603. [DOI: 10.1016/j.bbrc.2013.09.117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
305 Han H, Hu J, Lau MY, Feng M, Petrovic LM, Ji C. Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors. Front Genet 2013;4:224. [PMID: 24198826 DOI: 10.3389/fgene.2013.00224] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
306 Pestell RG. New roles of cyclin D1. Am J Pathol 2013;183:3-9. [PMID: 23790801 DOI: 10.1016/j.ajpath.2013.03.001] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 15.9] [Reference Citation Analysis]
307 Song NR, Lee E, Byun S, Kim JE, Mottamal M, Park JH, Lim SS, Bode AM, Lee HJ, Lee KW, Dong Z. Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma. Cancer Prev Res (Phila) 2013;6:1293-303. [PMID: 24104352 DOI: 10.1158/1940-6207.CAPR-13-0134] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
308 Allan G, Ouadid-Ahidouch H, Sanchez-Fernandez EM, Risquez-Cuadro R, Fernandez JM, Ortiz-Mellet C, Ahidouch A. New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells. PLoS One 2013;8:e76411. [PMID: 24124558 DOI: 10.1371/journal.pone.0076411] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
309 McCarty CM, Coffman JA. Developmental cis-regulatory analysis of the cyclin D gene in the sea urchin Strongylocentrotus purpuratus. Biochem Biophys Res Commun 2013;440:413-8. [PMID: 24090975 DOI: 10.1016/j.bbrc.2013.09.094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
310 Grabenstatter HL, Del Angel YC, Carlsen J, Wempe MF, White AM, Cogswell M, Russek SJ, Brooks-Kayal AR. The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy. Neurobiol Dis 2014;62:73-85. [PMID: 24051278 DOI: 10.1016/j.nbd.2013.09.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
311 Zins K, Lucas T, Reichl P, Abraham D, Aharinejad S. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice. PLoS One. 2013;8:e74924. [PMID: 24040362 DOI: 10.1371/journal.pone.0074924] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
312 Mishra SK, Kang JH, Lee CW, Oh SH, Ryu JS, Bae YS, Kim HM. Midazolam induces cellular apoptosis in human cancer cells and inhibits tumor growth in xenograft mice. Mol Cells 2013;36:219-26. [PMID: 24008365 DOI: 10.1007/s10059-013-0050-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
313 Otto T, Sicinski P. The kinase-independent, second life of CDK6 in transcription. Cancer Cell 2013;24:141-3. [PMID: 23948293 DOI: 10.1016/j.ccr.2013.07.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
314 Zhu S, Mott RT, Fry EA, Taneja P, Kulik G, Sui G, Inoue K. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer. Am J Pathol 2013;183:1339-50. [PMID: 23938323 DOI: 10.1016/j.ajpath.2013.06.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
315 Burke JF, Schlosser L, Harrison AD, Kunnimalaiyaan M, Chen H. MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition. Ann Surg Oncol 2013;20:3862-8. [PMID: 23900743 DOI: 10.1245/s10434-013-3168-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
316 Casimiro MC, Wang C, Li Z, Di Sante G, Willmart NE, Addya S, Chen L, Liu Y, Lisanti MP, Pestell RG. Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Mol Endocrinol 2013;27:1415-28. [PMID: 23864650 DOI: 10.1210/me.2013-1065] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
317 Tamm-Rosenstein K, Simm J, Suhorutshenko M, Salumets A, Metsis M. Changes in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencing. PLoS One 2013;8:e68907. [PMID: 23874806 DOI: 10.1371/journal.pone.0068907] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
318 Maneschi E, Vignozzi L, Morelli A, Mello T, Filippi S, Cellai I, Comeglio P, Sarchielli E, Calcagno A, Mazzanti B, Vettor R, Vannelli GB, Adorini L, Maggi M. FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. J Endocrinol. 2013;218:215-231. [PMID: 23750014 DOI: 10.1530/joe-13-0109] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
319 Dai M, Al-Odaini AA, Fils-Aimé N, Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S, Lebrun JJ. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res 2013;15:R49. [PMID: 23786849 DOI: 10.1186/bcr3441] [Cited by in Crossref: 61] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
320 Kriegel C, Attarwala H, Amiji M. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract. Adv Drug Deliv Rev 2013;65:891-901. [PMID: 23220324 DOI: 10.1016/j.addr.2012.11.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
321 Ou J, Deng J, Wei X, Xie G, Zhou R, Yu L, Liang H. Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells. Stem Cell Res. 2013;11:820-833. [PMID: 23811539 DOI: 10.1016/j.scr.2013.05.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
322 Brisken C. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 2013;13:385-96. [PMID: 23702927 DOI: 10.1038/nrc3518] [Cited by in Crossref: 179] [Cited by in F6Publishing: 180] [Article Influence: 17.9] [Reference Citation Analysis]
323 Cao Z, Zhang R, Li J, Huang H, Zhang D, Zhang J, Gao J, Chen J, Huang C. X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis. J Biol Chem 2013;288:20238-47. [PMID: 23720779 DOI: 10.1074/jbc.M112.448365] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
324 Koay MH, Crook M, Stewart CJ. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition. Histopathology. 2012;61:1125-1133. [PMID: 23190089 DOI: 10.1111/j.1365-2559.2012.04326.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
325 Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG. Cyclins and cell cycle control in cancer and disease. Genes Cancer 2012;3:649-57. [PMID: 23634253 DOI: 10.1177/1947601913479022] [Cited by in Crossref: 151] [Cited by in F6Publishing: 160] [Article Influence: 15.1] [Reference Citation Analysis]
326 Liu K, Liu XS, Yu MQ, Xu YJ. Change of extracellular signal-regulated kinase expression in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease. Exp Lung Res 2013;39:162-72. [PMID: 23614701 DOI: 10.3109/01902148.2013.788234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
327 Sabir M, Baig RM, Mahjabeen I, Kayani MA. Significance of cyclin D1 polymorphisms in patients with head and neck cancer. Int J Biol Markers. 2013;28:49-55. [PMID: 23125009 DOI: 10.5301/jbm.2012.9768] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
328 Stöckl S, Bauer RJ, Bosserhoff AK, Göttl C, Grifka J, Grässel S. Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci 2013;126:2890-902. [PMID: 23606745 DOI: 10.1242/jcs.124305] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
329 D'Inzeo S, Nicolussi A, Nardi F, Coppa A. Effects of the Smad4 C324Y mutation on thyroid cell proliferation. Int J Oncol 2013;42:1890-6. [PMID: 23591524 DOI: 10.3892/ijo.2013.1908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
330 Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MV, Ramakrishna S. Synthesis of pyrazolo[1,5-a]pyrimidine linked aminobenzothiazole conjugates as potential anticancer agents. Bioorg Med Chem Lett 2013;23:3208-15. [PMID: 23623491 DOI: 10.1016/j.bmcl.2013.03.129] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
331 Peer D. A daunting task: manipulating leukocyte function with RNAi. Immunol Rev 2013;253:185-97. [DOI: 10.1111/imr.12044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
332 Spiotto MT, Pytynia M, Liu GF, Ranck MC, Widau R. Animal models to study the mutational landscape for oral cavity and oropharyngeal cancers. J Oral Maxillofac Res 2013;4:e1. [PMID: 24422024 DOI: 10.5037/jomr.2013.4101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
333 Kelley AL, de Rivera CE, Buckley BA. Cold tolerance of the invasive Carcinus maenas in the east Pacific: molecular mechanisms and implications for range expansion in a changing climate. Biol Invasions 2013;15:2299-309. [DOI: 10.1007/s10530-013-0454-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
334 Zhang Y, Li Q, Huang W, Zhang J, Han Z, Wei H, Cui J, Wang Y, Yan W. Increased expression of apoptosis-related protein 3 is highly associated with tumorigenesis and progression of cervical squamous cell carcinoma. Human Pathology 2013;44:388-93. [DOI: 10.1016/j.humpath.2012.05.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
335 Lau MY, Han H, Hu J, Ji C. Association of cyclin D and estrogen receptor α36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress. J Gastroenterol Hepatol 2013;28:576-83. [PMID: 23216077 DOI: 10.1111/jgh.12084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
336 Pan C, Xu X, Tan L, Lin L, Pan Y. The effects of Porphyromonas gingivalis on the cell cycle progression of human gingival epithelial cells. Oral Dis 2014;20:100-8. [PMID: 23444918 DOI: 10.1111/odi.12081] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
337 Blessmann M, Al-Dam A, Hanken H, Assaf AT, Riecke B, Klatt J, Simon R, Sauter G, Heiland M, Kluwe L, Gröbe A. Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC). J Craniomaxillofac Surg 2013;41:845-9. [PMID: 23453270 DOI: 10.1016/j.jcms.2013.01.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
338 Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L, Liu Y, Gao Y, Xu D, Wang Q. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem. 2013;377:121-130. [PMID: 23417242 DOI: 10.1007/s11010-013-1576-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
339 Alvelos MI, Vinagre J, Fonseca E, Barbosa E, Teixeira-gomes J, Sobrinho-simões M, Soares P. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. European Journal of Endocrinology 2013;168:119-28. [DOI: 10.1530/eje-12-0327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
340 Caverzasio J, Biver E, Thouverey C. Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation. J Bone Miner Res 2013;28:260-70. [PMID: 22927028 DOI: 10.1002/jbmr.1748] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
341 Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, Yueyang B. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One 2013;8:e54932. [PMID: 23383003 DOI: 10.1371/journal.pone.0054932] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
342 Singh R, Mo YY. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14:201-212. [PMID: 23291983 DOI: 10.4161/cbt.23296] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 9.5] [Reference Citation Analysis]
343 Mori Y, Yagi S, Sakurai A, Matsuda M, Kiyokawa E. Insufficient ability of Rac1b to perturb cystogenesis. Small GTPases 2013;4:9-15. [PMID: 23411476 DOI: 10.4161/sgtp.23311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
344 Wang C, Pestell TG, Pestell RG. A New Perspective on Cyclin D1: Beyond Cell Cycle Regulation. Cell and Molecular Biology of Breast Cancer 2013. [DOI: 10.1007/978-1-62703-634-4_13] [Reference Citation Analysis]
345 Leiszter K, Galamb O, Sipos F, Krenács T, Veres G, Wichmann B, Kalmár A, Patai ÁV, Tóth K, Valcz G, Molnár B, Tulassay Z. Sporadic colorectal cancer development shows rejuvenescence regarding epithelial proliferation and apoptosis. PLoS One 2013;8:e74140. [PMID: 24098334 DOI: 10.1371/journal.pone.0074140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
346 Dai Y, Chen S, Yi L, Xu M. Targeting the Cell Cycle for Cancer Treatment and Neuroprotection. Trends in Stem Cell Proliferation and Cancer Research 2013. [DOI: 10.1007/978-94-007-6211-4_23] [Reference Citation Analysis]
347 Yu Z, Tozeren A, Pestell RG. Function of miRNAs in Tumor Cell Proliferation. MicroRNA in Cancer 2013. [DOI: 10.1007/978-94-007-4655-8_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
348 Silvan S, Manoharan S. Apigenin prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Archives of Oral Biology 2013;58:94-101. [DOI: 10.1016/j.archoralbio.2012.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
349 Lu J, Zhao H, Xu J, Zhang L, Yan L, Shen Z. Elevated cyclin D1 expression is governed by plasma IGF-1 through Ras/Raf/MEK/ERK pathway in rumen epithelium of goats supplying a high metabolizable energy diet. J Anim Physiol Anim Nutr 2013;97:1170-8. [DOI: 10.1111/jpn.12026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
350 Rezaei PF, Fouladdel S, Ghaffari SM, Amin G, Azizi E. Induction of G1 cell cycle arrest and cyclin D1 down-regulation in response to pericarp extract of Baneh in human breast cancer T47D cells. Daru 2012;20:101. [PMID: 23351343 DOI: 10.1186/2008-2231-20-101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
351 Yin R, Wang R, Guo L, Zhang W, Lu Y. MiR-17-3p inhibits angiogenesis by downregulating flk-1 in the cell growth signal pathway. J Vasc Res 2013;50:157-66. [PMID: 23258273 DOI: 10.1159/000345697] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
352 Mylona E, Tzelepis K, Theohari I, Giannopoulou I, Papadimitriou C, Nakopoulou L. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype. Histopathology 2013;62:472-80. [PMID: 23163571 DOI: 10.1111/his.12013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
353 Wang W, Zhao Y, Yang J, Lin B, Gu H, Cao X, Ge L. Cyclin D1 polymorphism and oral cancer: a meta-analysis. Mol Biol Rep 2013;40:87-95. [PMID: 23111452 DOI: 10.1007/s11033-012-2025-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
354 Dalvai M, Bellucci L, Fleury L, Lavigne AC, Moutahir F, Bystricky K. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression. Oncogene 2013;32:4243-51. [PMID: 23108396 DOI: 10.1038/onc.2012.442] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
355 Myklebust MP, Li Z, Tran TH, Rui H, Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, Tveit KM, Pestell RG, Dahl O. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. Br J Cancer 2012;107:1684-91. [PMID: 23099809 DOI: 10.1038/bjc.2012.463] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
356 Choi YJ, Li X, Hydbring P, Sanda T, Stefano J, Christie AL, Signoretti S, Look AT, Kung AL, von Boehmer H, Sicinski P. The requirement for cyclin D function in tumor maintenance. Cancer Cell 2012;22:438-51. [PMID: 23079655 DOI: 10.1016/j.ccr.2012.09.015] [Cited by in Crossref: 243] [Cited by in F6Publishing: 243] [Article Influence: 22.1] [Reference Citation Analysis]
357 Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ, Christensen R, Prindiville SA, Calzone KA, Soballe PW, Hu Y, Chowdhury SA, Schwartz R, Schäffer AA, Ried T. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 2012;181:1807-22. [PMID: 23062488 DOI: 10.1016/j.ajpath.2012.07.012] [Cited by in Crossref: 87] [Cited by in F6Publishing: 69] [Article Influence: 7.9] [Reference Citation Analysis]
358 Maneschi E, Morelli A, Filippi S, Cellai I, Comeglio P, Mazzanti B, Mello T, Calcagno A, Sarchielli E, Vignozzi L, Saad F, Vettor R, Vannelli GB, Maggi M. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. J Endocrinol 2012;215:347-62. [PMID: 23045189 DOI: 10.1530/JOE-12-0333] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
359 Jang KY, Kim YN, Bae JS, Chung MJ, Moon WS, Kang MJ, Lee DG, Park HS. Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma. Transl Oncol 2012;5:370-8. [PMID: 23066445 DOI: 10.1593/tlo.12220] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
360 Jares P, Colomer D, Campo E. Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 2012;122:3416-23. [PMID: 23023712 DOI: 10.1172/JCI61272] [Cited by in Crossref: 278] [Cited by in F6Publishing: 290] [Article Influence: 25.3] [Reference Citation Analysis]
361 Rajasekaran D, Manoharan S, Silvan S, Vasudevan K, Baskaran N, Palanimuthu D. Proapoptotic, anti-cell proliferative, anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Afr J Tradit Complement Altern Med 2012;10:102-12. [PMID: 24082331 DOI: 10.4314/ajtcam.v10i1.14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
362 Proietti S, Cucina A, Reiter RJ, Bizzarri M. Molecular mechanisms of melatonin’s inhibitory actions on breast cancers. Cell Mol Life Sci 2013;70:2139-57. [DOI: 10.1007/s00018-012-1161-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
363 Vízkeleti L, Ecsedi S, Rákosy Z, Orosz A, Lázár V, Emri G, Koroknai V, Kiss T, Ádány R, Balázs M. The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumour Biol 2012;33:2189-99. [PMID: 23001925 DOI: 10.1007/s13277-012-0480-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
364 Arulselvan P, Wen CC, Lan CW, Chen YH, Wei WC, Yang NS. Dietary administration of scallion extract effectively inhibits colorectal tumor growth: cellular and molecular mechanisms in mice. PLoS One 2012;7:e44658. [PMID: 23024755 DOI: 10.1371/journal.pone.0044658] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
365 Ptak A, Kolaczkowska E, Gregoraszczuk EL. Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine 2013;43:394-403. [PMID: 22968658 DOI: 10.1007/s12020-012-9788-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
366 Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget 2012;3:224-5. [PMID: 22538871 DOI: 10.18632/oncotarget.476] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
367 Milton SG, Mathew OP, Yatsu FM, Ranganna K. Differential cellular and molecular effects of butyrate and trichostatin a on vascular smooth muscle cells. Pharmaceuticals (Basel) 2012;5:925-43. [PMID: 24280698 DOI: 10.3390/ph5090925] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
368 Bajpai VK, Mistriotis P, Loh YH, Daley GQ, Andreadis ST. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res. 2012;96:391-400. [PMID: 22941255 DOI: 10.1093/cvr/cvs253] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.0] [Reference Citation Analysis]
369 Jirawatnotai S, Hu Y, Livingston DM, Sicinski P. Proteomic identification of a direct role for cyclin d1 in DNA damage repair. Cancer Res 2012;72:4289-93. [PMID: 22915759 DOI: 10.1158/0008-5472.CAN-11-3549] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
370 Lin CC, Chung YC, Hsu CP. Potential roles of longan flower and seed extracts for anti-cancer. World J Exp Med 2012; 2(4): 78-85 [PMID: 24520538 DOI: 10.5493/wjem.v2.i4.78] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
371 Chen CA, Cheng YC, Hwang JC, Chang JM, Guh JY, Chen HC. Cyclin D1 expression in podocytes: regulated by mitogens in collaboration with integrin-extracellular matrix interaction through extracellular signal-regulated kinase. Exp Biol Med (Maywood) 2012;237:516-23. [PMID: 22678010 DOI: 10.1258/ebm.2012.011156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
372 Dou H, Zhong W, Yang L, Wang T, Yan H, Hou Y. Synthesis, cytotoxic activities and cell cycle arrest profiles of half-sandwich N-sulfonamide based dithio-o-carborane metal complexes. Bioorganic & Medicinal Chemistry 2012;20:4693-700. [DOI: 10.1016/j.bmc.2012.06.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
373 Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, Towle HC, Chau AT, Albrecht JH. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. Cell Cycle 2012;11:2681-90. [PMID: 22751438 DOI: 10.4161/cc.21019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
374 Fu X, Tan D, Hou Z, Hu Z, Liu G. miR-338-3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3’-UTR Region of CyclinD1. Int J Mol Sci. 2012;13:8514-8539. [PMID: 22942717 DOI: 10.3390/ijms13078514] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
375 Korkmaz A, Rosales-corral S, Reiter RJ. Gene regulation by melatonin linked to epigenetic phenomena. Gene 2012;503:1-11. [DOI: 10.1016/j.gene.2012.04.040] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
376 Zhang J, Ouyang W, Li J, Zhang D, Yu Y, Wang Y, Li X, Huang C. Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability. Toxicol Appl Pharmacol 2012;263:218-24. [PMID: 22749963 DOI: 10.1016/j.taap.2012.06.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
377 Asher JM, O'Leary KA, Rugowski DE, Arendt LM, Schuler LA. Prolactin promotes mammary pathogenesis independently from cyclin D1. Am J Pathol 2012;181:294-302. [PMID: 22658484 DOI: 10.1016/j.ajpath.2012.03.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
378 Kundumani-Sridharan V, Van Quyen D, Subramani J, Singh NK, Chin YE, Rao GN. Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phase influencing cell migration and second phase directing cell proliferation. J Biol Chem 2012;287:22463-82. [PMID: 22566696 DOI: 10.1074/jbc.M112.362996] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
379 Sporn JC, Jung B. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer. Am J Pathol 2012;180:2516-26. [PMID: 22542848 DOI: 10.1016/j.ajpath.2012.02.027] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
380 Zollo M, Di Dato V, Spano D, De Martino D, Liguori L, Marino N, Vastolo V, Navas L, Garrone B, Mangano G. Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models. Clin Exp Metastasis. 2012;29:585-601. [PMID: 22484917 DOI: 10.1007/s10585-012-9473-5] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.7] [Reference Citation Analysis]
381 Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012;142:886-896.e9. [PMID: 22240480 DOI: 10.1053/j.gastro.2011.12.047] [Cited by in Crossref: 134] [Cited by in F6Publishing: 152] [Article Influence: 12.2] [Reference Citation Analysis]
382 Liu W, Han B, Sun B, Gao Y, Huang Y, Hu M. Overexpression of Interleukin-18 Induces Growth Inhibition, Apoptosis and Gene Expression Changes in a Human Tongue Squamous Cell Carcinoma Cell Line. J Int Med Res 2012;40:537-44. [DOI: 10.1177/147323001204000215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
383 Choschzick M, Hess S, Tennstedt P, Holst F, Bohlken H, Gieseking F, Mahner S, Woelber L, Simon R, Sauter G. Role of cyclin D1 amplification and expression in vulvar carcinomas. Hum Pathol 2012;43:1386-93. [PMID: 22406359 DOI: 10.1016/j.humpath.2011.11.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
384 Yu Y, Zhang Y, Hu J, Zhang H, Wang S, Han F, Yue L, Qu Y, Zhang Y, Liang H, Nie H, Li Y. MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma. Cancer Sci 2012;103:716-22. [PMID: 22320884 DOI: 10.1111/j.1349-7006.2012.02220.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
385 Agalakova NI, Gusev GP. Molecular Mechanisms of Cytotoxicity and Apoptosis Induced by Inorganic Fluoride. ISRN Cell Biology 2012;2012:1-16. [DOI: 10.5402/2012/403835] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 7.9] [Reference Citation Analysis]
386 Safwani WK, Makpol S, Sathapan S, Chua KH. The impact of long-term in vitro expansion on the senescence-associated markers of human adipose-derived stem cells. Appl Biochem Biotechnol 2012;166:2101-13. [PMID: 22391697 DOI: 10.1007/s12010-012-9637-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
387 Yu Z, Pestell RG. Small non-coding RNAs govern mammary gland tumorigenesis. J Mammary Gland Biol Neoplasia 2012;17:59-64. [PMID: 22382486 DOI: 10.1007/s10911-012-9246-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
388 Sas-Chen A, Avraham R, Yarden Y. A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer. J Mammary Gland Biol Neoplasia 2012;17:3-14. [PMID: 22327345 DOI: 10.1007/s10911-012-9243-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
389 Wang CY, Tsai AC, Peng CY, Chang YL, Lee KH, Teng CM, Pan SL. Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways. PLoS One 2012;7:e31195. [PMID: 22359572 DOI: 10.1371/journal.pone.0031195] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
390 Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, Wang C, Fortina P, Addya S, Tozeren A, Knudsen ES, Arnold A, Pestell RG. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. J Clin Invest 2012;122:833-43. [PMID: 22307325 DOI: 10.1172/JCI60256] [Cited by in Crossref: 87] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
391 Jadali Z, Jadali Z. Hepatitis C Virus Cryoglobulinemia and Non-Hodgkin Lymphoma. Hepat Mon 2012;12:85-91. [DOI: 10.5812/hepatmon.4905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
392 Jadali Z. Hepatitis C virus cryoglobulinemia and non-hodgkin lymphoma. Hepat Mon 2012;12:85-91. [PMID: 22509184 DOI: 10.5812/hepatmon.818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
393 Wang H, Kumar TR. Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis. Gene Expr Patterns 2012;12:136-44. [PMID: 22289519 DOI: 10.1016/j.gep.2012.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
394 Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer 2012;12:29. [PMID: 22260523 DOI: 10.1186/1471-2407-12-29] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
395 Liu FJ, Wen T, Liu L. MicroRNAs as a novel cellular senescence regulator. Ageing Res Rev 2012;11:41-50. [PMID: 21689787 DOI: 10.1016/j.arr.2011.06.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
396 Shah B, Martin P, Tao J, Sotomayor EM. Molecular Biology of Mantle Cell Lymphoma. Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics 2012. [DOI: 10.1007/978-94-007-5028-9_7] [Reference Citation Analysis]
397 Carvalho CM, Chang J, Lucas JE, Nevins JR, Wang Q, West M. High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics. J Am Stat Assoc 2008;103:1438-56. [PMID: 21218139 DOI: 10.1198/016214508000000869] [Cited by in Crossref: 250] [Cited by in F6Publishing: 254] [Article Influence: 22.7] [Reference Citation Analysis]
398 Zhang J, Gill AJ, Issacs JD, Atmore B, Johns A, Delbridge LW, Lai R, McMullen TP. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer. Hum Pathol 2012;43:1044-50. [PMID: 22204713 DOI: 10.1016/j.humpath.2011.08.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
399 Zhang ZJ, Ma SL. miRNAs in breast cancer tumorigenesis (Review). Oncol Rep 2012;27:903-10. [PMID: 22200848 DOI: 10.3892/or.2011.1611] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
400 Wang X, Zhang Y, Zhang X, Tian W, Feng W, Chen T. The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition. Int J Oncol 2012;40:1189-95. [PMID: 22179587 DOI: 10.3892/ijo.2011.1298] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
401 Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Res Treat. 2012;133:1025-1035. [PMID: 22147081 DOI: 10.1007/s10549-011-1901-8] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 5.7] [Reference Citation Analysis]
402 Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell Physiol. 2012;302:C676-C685. [PMID: 22116304 DOI: 10.1152/ajpcell.00180.2011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
403 Wang Z, Yan J, Zheng Q, Wang Z, Li J, Zhang X, Zhang S. Effects of biodegradable Mg–6Zn alloy extracts on cell cycle of intestinal epithelial cells. J Biomater Appl 2013;27:739-47. [DOI: 10.1177/0885328211424518] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
404 Xiao Y, Wang J, Lu J, Liu Y, Wang Y, Gao Y, Jin D. Down-regulation of cyclin D1 by small interfering RNA inhibits cell growth and induces apoptosis of laryngeal squamous cell carcinoma. Am J Otolaryngol 2011;32:541-6. [PMID: 21315488 DOI: 10.1016/j.amjoto.2010.11.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
405 Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012;31:2725-37. [PMID: 22002305 DOI: 10.1038/onc.2011.455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 8.4] [Reference Citation Analysis]
406 Velasco-Velázquez MA, Li Z, Casimiro M, Loro E, Homsi N, Pestell RG. Examining the role of cyclin D1 in breast cancer. Future Oncol. 2011;7:753-765. [PMID: 21675838 DOI: 10.2217/fon.11.56] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
407 Sun Z, Cao X, Jiang MM, Qiu Y, Zhou H, Chen L, Qin B, Wu H, Jiang F, Chen J, Liu J, Dai Y, Chen HF, Hu QY, Wu Z, Zeng JZ, Yao XS, Zhang XK. Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77. Oncogene 2012;31:2653-67. [PMID: 21986938 DOI: 10.1038/onc.2011.448] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
408 Daviau A, Couture JP, Blouin R. Loss of DLK expression in WI-38 human diploid fibroblasts induces a senescent-like proliferation arrest. Biochem Biophys Res Commun 2011;413:282-7. [PMID: 21893036 DOI: 10.1016/j.bbrc.2011.08.086] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
409 Ito M, Kusunoki H, Mochida K, Yamaguchi K, Mizuochi T. HCV infection and B-cell lymphomagenesis. Adv Hematol 2011;2011:835314. [PMID: 21789042 DOI: 10.1155/2011/835314] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
410 Advani SH. Targeting mTOR pathway: A new concept in cancer therapy. Indian J Med Paediatr Oncol. 2010;31:132-136. [PMID: 21584218 DOI: 10.4103/0971-5851.76197] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
411 Karlsson E, Waltersson MA, Bostner J, Pérez-Tenorio G, Olsson B, Hallbeck AL, Stål O. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Genes Chromosomes Cancer 2011;50:775-87. [PMID: 21748818 DOI: 10.1002/gcc.20900] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
412 Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011;11:558-72. [PMID: 21734724 DOI: 10.1038/nrc3090] [Cited by in Crossref: 962] [Cited by in F6Publishing: 1009] [Article Influence: 80.2] [Reference Citation Analysis]
413 Yan H, Wu J, Liu W, Zuo Y, Chen S, Zhang S, Zeng M, Huang W. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum Gene Ther. 2010;21:1723-1734. [PMID: 20583868 DOI: 10.1089/hum.2010.061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
414 Lukaszewicz AI, Anderson DJ. Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner. Proc Natl Acad Sci U S A 2011;108:11632-7. [PMID: 21709239 DOI: 10.1073/pnas.1106230108] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
415 Noonan EJ, Place RF, Basak S, Pookot D, Li LC. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 2010;1:349-58. [PMID: 20948989 DOI: 10.18632/oncotarget.167] [Cited by in Crossref: 106] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
416 Chowdhury P, Pore D, Mahata N, Karmakar P, Pal A, Chakrabarti MK. Thermostable direct hemolysin downregulates human colon carcinoma cell proliferation with the involvement of E-cadherin, and β-catenin/Tcf-4 signaling. PLoS One. 2011;6:e20098. [PMID: 21625458 DOI: 10.1371/journal.pone.0020098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
417 Nakajima K, Inagawa M, Uchida C, Okada K, Tane S, Kojima M, Kubota M, Noda M, Ogawa S, Shirato H, Sato M, Suzuki-migishima R, Hino T, Satoh Y, Kitagawa M, Takeuchi T. Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway. Development 2011;138:1771-82. [DOI: 10.1242/dev.059295] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
418 de Vreeze RS, van Coevorden F, Boerrigter L, Nederlof PM, Haas RL, Bras J, Rosenwald A, Mentzel T, de Jong D. Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysis. Sarcoma 2011;2011:638403. [PMID: 21559269 DOI: 10.1155/2011/638403] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
419 Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL, Lv X, Zhang QJ, Zhang R, Wang Z, She ZG, Zhang R, Wei YS, Du GH, Liu DP, Liang CC. SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 2011;108:1180-9. [PMID: 21474819 DOI: 10.1161/CIRCRESAHA.110.237875] [Cited by in Crossref: 134] [Cited by in F6Publishing: 142] [Article Influence: 11.2] [Reference Citation Analysis]
420 Maussang D, Bongers G, Lira SA, Smit MJ. Constitutively Active Viral Chemokine Receptors: Tools for Immune Subversion and Pathogenesis. Methods and Principles in Medicinal Chemistry 2011. [DOI: 10.1002/9783527631995.ch9] [Reference Citation Analysis]
421 Anandharaj A, Cinghu S, Park WY. Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai) 2011;43:292-300. [PMID: 21367753 DOI: 10.1093/abbs/gmr012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
422 Schaefer IM, Enders C, Polten A, Haller F, Frölich AM, Cameron S, Schüler P, Schweiger P, Gunawan B, Beham A, Füzesi L. Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. Am J Clin Pathol 2011;135:579-86. [PMID: 21411780 DOI: 10.1309/AJCPZ1O7UUUISPNR] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
423 Fleischmann A, Rocha C, Saxer-Sekulic N, Zlobec I, Sauter G, Thalmann GN. High-level cytoplasmic cyclin D1 expression in lymph node metastases from prostate cancer independently predicts early biochemical failure and death in surgically treated patients. Histopathology 2011;58:781-9. [PMID: 21438905 DOI: 10.1111/j.1365-2559.2011.03800.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
424 Velpula KK, Dasari VR, Tsung AJ, Gondi CS, Klopfenstein JD, Mohanam S, Rao JS. Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1. PLoS One 2011;6:e18017. [PMID: 21455311 DOI: 10.1371/journal.pone.0018017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
425 Kriegel C, Amiji MM. Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2011;2:e2. [PMID: 23237848 DOI: 10.1038/ctg.2011.1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
426 Mathew OP, Ranganna K, Yatsu FM. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother. 2010;64:733-740. [PMID: 20970954 DOI: 10.1016/j.biopha.2010.09.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
427 Chen RJ, Chang LW, Lin P, Wang YJ. Epigenetic effects and molecular mechanisms of tumorigenesis induced by cigarette smoke: an overview. J Oncol 2011;2011:654931. [PMID: 21559255 DOI: 10.1155/2011/654931] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
428 Capaldo CT, Koch S, Kwon M, Laur O, Parkos CA, Nusrat A. Tight function zonula occludens-3 regulates cyclin D1-dependent cell proliferation. Mol Biol Cell 2011;22:1677-85. [PMID: 21411630 DOI: 10.1091/mbc.E10-08-0677] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
429 Stewart CJR, Crook ML, Little L, Louwen K. Correlation between invasive pattern and immunophenotypic alterations in endocervical adenocarcinoma: Endocervical adenocarcinoma. Histopathology 2011;58:720-8. [DOI: 10.1111/j.1365-2559.2011.03787.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
430 Zhao X, Guo J, Yu Y, Yi S, Yu T, Fu L, Hou L, Chen W. Overexpression of survivin and cyclin D1 in CHO cells confers apoptosis resistance and enhances growth in serum-free suspension culture. Biotechnol Lett 2011;33:1293-300. [DOI: 10.1007/s10529-011-0577-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
431 Guo ZY, Hao XH, Tan FF, Pei X, Shang LM, Jiang XL, Yang F. The elements of human cyclin D1 promoter and regulation involved. Clin Epigenetics 2011;2:63-76. [PMID: 22704330 DOI: 10.1007/s13148-010-0018-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
432 Kim JW, Rhee CK, Kim TJ, Kim YH, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, Kim KH, Kim YK. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. Clin Exp Pharmacol Physiol 2010;37:1055-63. [PMID: 20659133 DOI: 10.1111/j.1440-1681.2010.05431.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
433 Bates CA, Pomerantz WC, Mapp AK. Transcriptional tools: Small molecules for modulating CBP KIX-dependent transcriptional activators. Biopolymers 2011;95:17-23. [PMID: 20882601 DOI: 10.1002/bip.21548] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
434 Wang R, Xu YJ, Liu XS, Zeng DX, Xiang M. Knockdown of connective tissue growth factor by plasmid-based short hairpin RNA prevented pulmonary vascular remodeling in cigarette smoke-exposed rats. Arch Biochem Biophys 2011;508:93-100. [PMID: 21295007 DOI: 10.1016/j.abb.2011.01.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
435 Hussain S, M Y, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, Siddiqi MA, Das BC, Bharadwaj M. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog. 2011;50:487-498. [PMID: 21268129 DOI: 10.1002/mc.20732] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
436 Fernández RM, Ruiz-Miró M, Dolcet X, Aldea M, Garí E. Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility. Oncogene 2011;30:1936-46. [PMID: 21242975 DOI: 10.1038/onc.2010.577] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
437 Wang X, Wolgemuth DJ, Baxi LV. Overexpression of HOXB5, Cyclin D1 and PCNA in Congenital Cystic Adenomatoid Malformation. Fetal Diagn Ther 2011;29:315-20. [DOI: 10.1159/000322738] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
438 Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. J Biol Chem. 2011;286:8117-8127. [PMID: 21212260 DOI: 10.1074/jbc.m110.170720] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
439 Meng H, Tian L, Zhou J, Li Z, Jiao X, Li WW, Plomann M, Xu Z, Lisanti MP, Wang C, Pestell RG. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b. Cell Cycle 2011;10:73-81. [PMID: 21200149 DOI: 10.4161/cc.10.1.14243] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
440 Kamal A, Shetti RVCRNC, Ramaiah MJ, Swapna P, Reddy KS, Mallareddy A, Rao MPN, Chourasia M, Sastry GN, Juvekar A, Zingde S, Sarma P, Pushpavalli SNCVL, Pal-bhadra M. Carbazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates: design, synthesis, and biological evaluation. Med Chem Commun 2011;2:780. [DOI: 10.1039/c1md00072a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
441 Conti A, Rodriguez GC, Chiechi A, Blazquez RM, Barbado V, Krènacs T, Novello C, Pazzaglia L, Quattrini I, Zanella L, Picci P, De Alava E, Benassi MS. Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. Am J Pathol 2011;178:88-97. [PMID: 21224047 DOI: 10.1016/j.ajpath.2010.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
442 Stamatakos M, Palla V, Karaiskos I, Xiromeritis K, Alexiou I, Pateras I, Kontzoglou K. Cell cyclins: triggering elements of cancer or not? World J Surg Oncol. 2010;8:111. [PMID: 21176227 DOI: 10.1186/1477-7819-8-111] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
443 Good DJ, Gascoyne RD. Molecular pathology of lymphoma. Management of Hematologic Malignancies 2010. [DOI: 10.1017/cbo9780511781926.014] [Reference Citation Analysis]
444 Goy A. Mantle cell lymphoma. Management of Hematologic Malignancies 2010. [DOI: 10.1017/cbo9780511781926.017] [Reference Citation Analysis]
445 Heathcote DA, Patel H, Kroll SH, Hazel P, Periyasamy M, Alikian M, Kanneganti SK, Jogalekar AS, Scheiper B, Barbazanges M, Blum A, Brackow J, Siwicka A, Pace RD, Fuchter MJ, Snyder JP, Liotta DC, Freemont PS, Aboagye EO, Coombes RC, Barrett AG, Ali S. A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration. J Med Chem 2010;53:8508-22. [PMID: 21080703 DOI: 10.1021/jm100732t] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
446 Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE. Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene. 2011;30:1402-1412. [PMID: 21076466 DOI: 10.1038/onc.2010.521] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
447 Lian J, Tian H, Liu L, Zhang XS, Li WQ, Deng YM, Yao GD, Yin MM, Sun F. Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis 2010;1:e94. [PMID: 21368870 DOI: 10.1038/cddis.2010.70] [Cited by in Crossref: 107] [Cited by in F6Publishing: 116] [Article Influence: 8.2] [Reference Citation Analysis]
448 Saxena NK, Fu PP, Nagalingam A, Wang J, Handy J, Cohen C, Tighiouart M, Sharma D, Anania FA. Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology 2010;139:1762-73, 1773.e1-5. [PMID: 20637208 DOI: 10.1053/j.gastro.2010.07.001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 120] [Article Influence: 8.2] [Reference Citation Analysis]
449 Huang YC, Hung WC, Chen WT, Jiang WH, Yu HS, Chai CY. Effects of MEK and DNMT inhibitors on arsenic-treated human uroepithelial cells in relation to Cyclin-D1 and p16. Toxicol Lett 2011;200:59-66. [PMID: 21040761 DOI: 10.1016/j.toxlet.2010.10.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
450 Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, Wang M, Soutoglou E, Knudsen ES, Pestell RG. Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res 2010;70:8802-11. [PMID: 20940395 DOI: 10.1158/0008-5472.CAN-10-0312] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
451 Zhao Y, Zhou Y, O' Boyle KM, Murphy PV. Biological study of the angiogenesis inhibitor N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin. Chem Biol Drug Des 2010;75:570-7. [PMID: 20565474 DOI: 10.1111/j.1747-0285.2010.00968.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
452 McCrea PD, Gu D, Balda MS. Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity. Cold Spring Harb Perspect Biol 2009;1:a002923. [PMID: 20066098 DOI: 10.1101/cshperspect.a002923] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
453 Sommer G, Dittmann J, Kuehnert J, Reumann K, Schwartz PE, Will H, Coulter BL, Smith MT, Heise T. The RNA-binding protein La contributes to cell proliferation and CCND1 expression. Oncogene 2011;30:434-44. [PMID: 20856207 DOI: 10.1038/onc.2010.425] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
454 Mruk DD, Cheng CY. Tight junctions in the testis: new perspectives. Philos Trans R Soc Lond B Biol Sci 2010;365:1621-35. [PMID: 20403874 DOI: 10.1098/rstb.2010.0010] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
455 Li Y, Lu H, Huang Y, Xiao R, Cai X, He S, Yan G. Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells. Int J Cancer 2010;127:1271-82. [PMID: 19882709 DOI: 10.1002/ijc.25020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
456 Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 2010;12:415-24. [PMID: 20454513 DOI: 10.1593/neo.10188] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 6.2] [Reference Citation Analysis]
457 Malonia SK, Sinha S, Lakshminarasimhan P, Singh K, Jalota-Badhwar A, Rampalli S, Kaul-Ghanekar R, Chattopadhyay S. Gene regulation by SMAR1: Role in cellular homeostasis and cancer. Biochim Biophys Acta 2011;1815:1-12. [PMID: 20709157 DOI: 10.1016/j.bbcan.2010.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
458 Gravina GL, Marampon F, Di Staso M, Bonfili P, Vitturini A, Jannini EA, Pestell RG, Tombolini V, Festuccia C. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors. Prostate 2010;70:1166-78. [PMID: 20333699 DOI: 10.1002/pros.21151] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
459 Tang H, Murphy CJ, Zhang B, Shen Y, Sui M, Van Kirk EA, Feng X, Murdoch WJ. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects. Nanomedicine 2010;5:855-65. [DOI: 10.2217/nnm.10.67] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 5.8] [Reference Citation Analysis]
460 Alexander HM, Young E, Harries LW, Joyner M, Newman P, Sarsfield P. An unusual case of cyclin-D1-positive peripheral T cell lymphoma with a 11:14 translocation. J Hematopathol 2010;3:77-81. [DOI: 10.1007/s12308-010-0063-7] [Reference Citation Analysis]
461 Friel AM, Corcoran C, Crown J, O'Driscoll L. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. Breast Cancer Res Treat 2010;123:613-25. [PMID: 20549336 DOI: 10.1007/s10549-010-0980-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
462 Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone 2010;47:573-82. [PMID: 20541046 DOI: 10.1016/j.bone.2010.06.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
463 Mullany LK, Hanse EA, Romano A, Blomquist CH, Mason JI, Delvoux B, Anttila C, Albrecht JH. Cyclin D1 regulates hepatic estrogen and androgen metabolism. Am J Physiol Gastrointest Liver Physiol 2010;298:G884-95. [PMID: 20338923 DOI: 10.1152/ajpgi.00471.2009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
464 Marcus NY, Brunt EM, Blomenkamp K, Ali F, Rudnick DA, Ahmad M, Teckman JH. Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res 2010;40:641-53. [PMID: 20618460 DOI: 10.1111/j.1872-034X.2010.00663.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
465 Marsaud V, Tchakarska G, Andrieux G, Liu JM, Dembele D, Jost B, Wdzieczak-Bakala J, Renoir JM, Sola B. Cyclin K and cyclin D1b are oncogenic in myeloma cells. Mol Cancer 2010;9:103. [PMID: 20459741 DOI: 10.1186/1476-4598-9-103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
466 Qian N, Ueno T. Is Dysfunction of Caveolin-1 a Link Between Systemic Sclerosis and Breast Cancer, Opening a Window on Both Etiologies? Archives of Medical Research 2010;41:297-301. [DOI: 10.1016/j.arcmed.2010.05.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
467 Hwang E, Lee HJ. Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells. International Journal of Food Sciences and Nutrition 2010;61:324-36. [DOI: 10.3109/09637481003639092] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
468 Khandelwal P, Padala MK, Cox J, Guntaka RV. The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1. Int J Cell Biol 2009;2009:243532. [PMID: 20414334 DOI: 10.1155/2009/243532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
469 Chen YY, Li BA, Wang HD, Liu XY, Tan GW, Ma YH, Shen SH, Zhu HW, Wang ZX. The role of Pygopus 2 in rat glioma cell growth. Med Oncol. 2011;28:631-640. [PMID: 20361361 DOI: 10.1007/s12032-010-9488-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
470 Little L, Stewart CJ. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod Pathol 2010;23:611-8. [PMID: 20062011 DOI: 10.1038/modpathol.2009.178] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
471 Chen J, Feilotter HE, Paré GC, Zhang X, Pemberton JG, Garady C, Lai D, Yang X, Tron VA. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010;176:2520-9. [PMID: 20304954 DOI: 10.2353/ajpath.2010.091061] [Cited by in Crossref: 190] [Cited by in F6Publishing: 199] [Article Influence: 14.6] [Reference Citation Analysis]
472 Witzel II, Koh LF, Perkins ND. Regulation of cyclin D1 gene expression. Biochem Soc Trans 2010;38:217-22. [PMID: 20074063 DOI: 10.1042/BST0380217] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
473 Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res. 2010;70:2368-2378. [PMID: 20215518 DOI: 10.1158/0008-5472.can-09-3249] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
474 Ito M, Murakami K, Suzuki T, Mochida K, Suzuki M, Ikebuchi K, Yamaguchi K, Mizuochi T. Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol. 2010;135:459-465. [PMID: 20189883 DOI: 10.1016/j.clim.2010.02.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
475 Salomoni P, Calegari F. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol 2010;20:233-43. [PMID: 20153966 DOI: 10.1016/j.tcb.2010.01.006] [Cited by in Crossref: 198] [Cited by in F6Publishing: 184] [Article Influence: 15.2] [Reference Citation Analysis]
476 Freier K, Hofele C, Knoepfle K, Gross M, Devens F, Dyckhoff G, Plinkert P, Lichter P, Herold-Mende C. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes. J Oral Pathol Med 2010;39:382-9. [PMID: 20149059 DOI: 10.1111/j.1600-0714.2009.00864.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
477 Bassiouny AE, Nosseir MM, Zoheiry MK, Ameen NA, Abdel-Hadi AM, Ibrahim IM, Zada S, El-Deen AH, El-Bassiouni NE. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World J Hepatol 2010;2:32-41. [PMID: 21160954 DOI: 10.4254/wjh.v2.i1.32] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
478 Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG. microRNA, cell cycle, and human breast cancer. Am J Pathol. 2010;176:1058-1064. [PMID: 20075198 DOI: 10.2353/ajpath.2010.090664] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 7.6] [Reference Citation Analysis]
479 Lu J, Zheng J, Liu H, Li J, Xu Q, Chen K. Proteomics analysis of liver samples from puffer fish Takifugu rubripes exposed to excessive fluoride: An insight into molecular response to fluorosis. J Biochem Mol Toxicol 2010;24:21-8. [DOI: 10.1002/jbt.20308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
480 Zhang D, Trudeau VL. Estrogen Signaling Mechanisms. Signal Transduction: Pathways, Mechanisms and Diseases 2010. [DOI: 10.1007/978-3-642-02112-1_15] [Reference Citation Analysis]
481 Denner L, Howe M, Urban RJ. Signaling Pathways Regulating Growth and Differentiation of Adult Stem Cells. Handbook of Cell Signaling 2010. [DOI: 10.1016/b978-0-12-374145-5.00320-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
482 Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010;21:41-9. [PMID: 19896866 DOI: 10.1016/j.tem.2009.08.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
483 Kalpana GV, Smith ME. Development of Targeted Therapies for Rhabdoid Tumors Based on the Functions of INI1/hSNF5 Tumor Suppressor. Molecularly Targeted Therapy for Childhood Cancer 2010. [DOI: 10.1007/978-0-387-69062-9_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
484 Dancau A, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wencke K, Monni O, Simon R. PPFIA1 and CCND1 are frequently coamplified in breast cancer. Genes Chromosom Cancer 2010;49:1-8. [DOI: 10.1002/gcc.20713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
485 Lange C, Huttner WB, Calegari F. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell. 2009;5:320-331. [PMID: 19733543 DOI: 10.1016/j.stem.2009.05.026] [Cited by in Crossref: 406] [Cited by in F6Publishing: 426] [Article Influence: 29.0] [Reference Citation Analysis]
486 Li J, Jia H, Xie L, Wang X, Wang X, He H, Lin Y, Hu L. Association of Constitutive Nuclear Factor-κB Activation With Aggressive Aspects and Poor Prognosis in Cervical Cancer: . International Journal of Gynecological Cancer 2009;19:1421-6. [DOI: 10.1111/igc.0b013e3181b70445] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
487 Deharvengt SJ, Gunn JR, Pickett SB, Korc M. Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth. Cancer Gene Ther 2010;17:325-33. [PMID: 19851352 DOI: 10.1038/cgt.2009.75] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
488 Rajamanickam S, Kaur M, Velmurugan B, Singh RP, Agarwal R. Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway. Pharm Res 2009;26:2558-67. [PMID: 19779968 DOI: 10.1007/s11095-009-9968-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
489 Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, Kumar R, Wang C, Pestell RG. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res 2009;69:5752-60. [PMID: 19605405 DOI: 10.1158/0008-5472.CAN-08-3992] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
490 Wilkey JF, Buchberger G, Saucier K, Patel SM, Eisenberg E, Nakagawa H, Michaylira CZ, Rustgi AK, Mallya SM. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog 2009;48:853-61. [PMID: 19263437 DOI: 10.1002/mc.20531] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
491 Hanse EA, Nelsen CJ, Goggin MM, Anttila CK, Mullany LK, Berthet C, Kaldis P, Crary GS, Kuriyama R, Albrecht JH. Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo. Cell Cycle 2009;8:2802-9. [PMID: 19652536 DOI: 10.4161/cc.8.17.9465] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
492 Nie M, Aijaz S, Leefa Chong San IV, Balda MS, Matter K. The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription. EMBO Rep 2009;10:1125-31. [PMID: 19730435 DOI: 10.1038/embor.2009.182] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
493 Mayo C, Mayol X. Cycling D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells. Cancer Letters 2009;281:183-7. [DOI: 10.1016/j.canlet.2009.02.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
494 Fang YJ, Lu ZH, Wang GQ, Pan ZZ, Zhou ZW, Yun JP, Zhang MF, Wan DS. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 2009;24:875-84. [PMID: 19421758 DOI: 10.1007/s00384-009-0725-z] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 9.6] [Reference Citation Analysis]
495 Ali S, Heathcote DA, Kroll SH, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res. 2009;69:6208-6215. [PMID: 19638587 DOI: 10.1158/0008-5472.CAN-09-0301] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 7.1] [Reference Citation Analysis]
496 Martínez Díaz-Guerra G, Hawkins Carranza F. [Concept, etiology and epidemiology of primary hyperparathyroidism]. Endocrinol Nutr 2009;56 Suppl 1:2-7. [PMID: 19627754 DOI: 10.1016/S1575-0922(09)70849-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
497 Singh RP, Raina K, Deep G, Chan D, Agarwal R. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clin Cancer Res 2009;15:613-21. [PMID: 19147767 DOI: 10.1158/1078-0432.CCR-08-1846] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
498 Fu X, Cui Y, Lin G, Wang T. Non-genomic effects of 17β-estradiol in activation of the ERK1/ERK2 pathway induces cell proliferation through upregulation of cyclin D1 expression in bovine artery endothelial cells. Gynecological Endocrinology 2009;23:131-7. [DOI: 10.1080/09513590601181457] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
499 Kosaka N, Sakamoto H, Terada M, Ochiya T. Pleiotropic function of FGF-4: its role in development and stem cells. Dev Dyn 2009;238:265-76. [PMID: 18792115 DOI: 10.1002/dvdy.21699] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
500 Rojas P, Benavides F, Blando J, Perez C, Cardenas K, Richie E, Knudsen ES, Johnson DG, Senderowicz AM, Rodriguez-Puebla ML, Conti CJ. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b). Mol Carcinog 2009;48:508-16. [PMID: 18942117 DOI: 10.1002/mc.20489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
501 Velasco-Velázquez MA, Yu Z, Jiao X, Pestell RG. Cancer stem cells and the cell cycle: targeting the drive behind breast cancer. Expert Rev Anticancer Ther 2009;9:275-9. [PMID: 19275505 DOI: 10.1586/14737140.9.3.275] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
502 Soares de Sá BC, Fugimori ML, Braga Ribeiro KDC, Duprat Neto JP, Neves RI, Landman G. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. Melanoma Research 2009;19:135-41. [DOI: 10.1097/cmr.0b013e32831993f3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
503 Chand AL, Simpson ER, Clyne CD; kConFab. Aromatase expression is increased in BRCA1 mutation carriers. BMC Cancer 2009;9:148. [PMID: 19445691 DOI: 10.1186/1471-2407-9-148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
504 Fernández-Martínez AB, Bajo AM, Sánchez-Chapado M, Prieto JC, Carmena MJ. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells. Prostate 2009;69:774-86. [PMID: 19189304 DOI: 10.1002/pros.20930] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
505 Abboudi Z, Patel K, Naresh KN. Cyclin D1 expression in typical chronic lymphocytic leukaemia. Eur J Haematol 2009;83:203-7. [PMID: 19467018 DOI: 10.1111/j.1600-0609.2009.01276.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
506 Yang F, Xu YP, Li J, Duan SS, Fu YJ, Zhang Y, Zhao Y, Qiao WT, Chen QM, Geng YQ, Che CY, Cao YL, Wang Y, Zhang L, Long L, He J, Cui QC, Chen SC, Wang SH, Liu L. Cloning and characterization of a novel intracellular protein p48.2 that negatively regulates cell cycle progression. Int J Biochem Cell Biol 2009;41:2240-50. [PMID: 19427400 DOI: 10.1016/j.biocel.2009.04.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
507 Schurko AM, Logsdon JM Jr, Eads BD. Meiosis genes in Daphnia pulex and the role of parthenogenesis in genome evolution. BMC Evol Biol 2009;9:78. [PMID: 19383157 DOI: 10.1186/1471-2148-9-78] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
508 Park SG, Min JY, Chung C, Hsieh A, Jung G. Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx. Cancer Lett. 2009;282:229-237. [PMID: 19375220 DOI: 10.1016/j.canlet.2009.03.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
509 Rogers HA, Miller S, Lowe J, Brundler MA, Coyle B, Grundy RG. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). Br J Cancer 2009;100:1292-302. [PMID: 19293793 DOI: 10.1038/sj.bjc.6604979] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
510 Cengiz E, Karaca B, Kucukzeybek Y, Gorumlu G, Gul MK, Erten C, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R. Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination. Mol Biol Rep 2010;37:1269-77. [PMID: 19288219 DOI: 10.1007/s11033-009-9501-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
511 Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J Cell Physiol 2009;218:490-500. [DOI: 10.1002/jcp.21622] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
512 Klein EA, Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 2008;121:3853-7. [PMID: 19020303 DOI: 10.1242/jcs.039131] [Cited by in Crossref: 261] [Cited by in F6Publishing: 271] [Article Influence: 18.6] [Reference Citation Analysis]
513 Sohn D, Graupner V, Neise D, Essmann F, Schulze-osthoff K, Jänicke RU. Pifithrin-α protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ 2009;16:869-78. [DOI: 10.1038/cdd.2009.17] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 5.6] [Reference Citation Analysis]
514 Raychaudhuri S, Fontanes V, Barat B, Dasgupta A. Activation of ribosomal RNA transcription by hepatitis C virus involves upstream binding factor phosphorylation via induction of cyclin D1. Cancer Res. 2009;69:2057-2064. [PMID: 19223538 DOI: 10.1158/0008-5472.CAN-08-3468] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
515 Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW, Janssen KP, Robine S, Velcich A, Augenlicht LH, Black AR, Black JD. PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 2009;315:1415-28. [PMID: 19232344 DOI: 10.1016/j.yexcr.2009.02.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
516 Nishi K, Inoue H, Schnier JB, Rice RH. Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J Cell Biochem 2009;106:63-72. [PMID: 19021145 DOI: 10.1002/jcb.21978] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
517 Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Zeldenrust S, Kumar S, Hayman S, Buadi F, Kyle RA, Greipp PR, Lust JA, Russell S, Rajkumar SV, Fonseca R, Dispenzieri A. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Haematologica 2009;94:380-6. [PMID: 19211640 DOI: 10.3324/haematol.13369] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 5.2] [Reference Citation Analysis]
518 Tejada S, Lobo MV, García-Villanueva M, Sacristán S, Pérez-Morgado MI, Salinas M, Martín ME. Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors. J Histochem Cytochem 2009;57:503-12. [PMID: 19188486 DOI: 10.1369/jhc.2009.952929] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
519 Rabkin SW, Klassen SS. Jumonji is a potential regulatory factor mediating nitric oxide-induced modulation of cardiac hypertrophy. Journal of Cardiovascular Medicine 2009;10:206-11. [DOI: 10.2459/jcm.0b013e3283212ecd] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
520 Baranda-Avila N, Mendoza-Rodríguez CA, Morimoto S, Langley E, Cerbón M. Molecular mechanism of cell proliferation in rodent uterus during the estrous cycle. J Steroid Biochem Mol Biol 2009;113:259-68. [PMID: 19429431 DOI: 10.1016/j.jsbmb.2009.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
521 Patil MA, Lee SA, Macias E, Lam ET, Xu C, Jones KD, Ho C, Rodriguez-Puebla M, Chen X. Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis. Cancer Res. 2009;69:253-261. [PMID: 19118010 DOI: 10.1158/0008-5472.can-08-2514] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
522 Takai N, Ueda T, Nasu K, Yamashita S, Toyofuku M, Narahara H. Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas. Cancer Lett 2009;277:235-43. [PMID: 19168280 DOI: 10.1016/j.canlet.2008.12.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
523 Andrew AS, Mason RA, Memoli V, Duell EJ. Arsenic activates EGFR pathway signaling in the lung. Toxicol Sci 2009;109:350-7. [PMID: 19168569 DOI: 10.1093/toxsci/kfp015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
524 Liao YJ, Liu SP, Lee CM, Yen CH, Chuang PC, Chen CY, Tsai TF, Huang SF, Lee YH, Chen YM. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility. Int J Cancer. 2009;124:816-826. [PMID: 19035462 DOI: 10.1002/ijc.23979] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
525 Kim YJ, Yoon SY, Kim JT, Choi SC, Lim JS, Kim JH, Song EY, Lee HG, Choi I, Kim JW. NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer 2009;124:7-15. [PMID: 18844221 DOI: 10.1002/ijc.23945] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
526 Aronovitz A, Josefson J, Fisher A, Newman M, Hughes E, Chen F, Moons DS, Kiyokawa H, Lowe WL Jr. Rapamycin inhibits growth factor-induced cell cycle regulation in pancreatic beta cells. J Investig Med 2008;56:985-96. [PMID: 19105244 DOI: 10.2310/JIM.0b013e31818ce763] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
527 Żebracka-gala J, Waler J, Gawrychowski J, Hasse-lazar K, Kowalska M, Niemiec A, Szpak-ulczok S, Jurecka-lubieniecka B, Buła G, Truchanowski W, Gubała E, Jarząb B. Jun Gene Expression is Decreased in Parathyroid Adenoma. Polish Journal of Surgery 2009;81. [DOI: 10.2478/v10035-009-0075-0] [Reference Citation Analysis]
528 Roberti A, Macaluso M, Giordano A. Alterations in Cell Cycle Regulatory Genes in Breast Cancer. Breast Cancer in the Post-Genomic Era 2009. [DOI: 10.1007/978-1-60327-945-1_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
529 Nadiminty N, Gao AC. Selenium and Androgen Receptor in Prostate Cancer. Androgen Action in Prostate Cancer 2009. [DOI: 10.1007/978-0-387-69179-4_33] [Reference Citation Analysis]
530 Eskandarpour M, Huang F, Reeves KA, Clark E, Hansson J. Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro. Int J Cancer 2009;124:16-26. [DOI: 10.1002/ijc.23876] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
531 Chen Z, Ehsanian R, Van Waes C. Nuclear Transcription Factors and Signaling Pathways in Oral Cancer Metastasis. Oral Cancer Metastasis 2009. [DOI: 10.1007/978-1-4419-0775-2_10] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
532 Beyrouthy MJ, Alexander KE, Baldwin A, Whitfield ML, Bass HW, McGee D, Hurt MM. Identification of G1-regulated genes in normally cycling human cells. PLoS One 2008;3:e3943. [PMID: 19079774 DOI: 10.1371/journal.pone.0003943] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
533 Schiewer MJ, Morey LM, Burd CJ, Liu Y, Merry DE, Ho SM, Knudsen KE. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer. Oncogene. 2009;28:1016-1027. [PMID: 19079343 DOI: 10.1038/onc.2008.446] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
534 Balda MS, Matter K. Tight junctions and the regulation of gene expression. Biochim Biophys Acta 2009;1788:761-7. [PMID: 19121284 DOI: 10.1016/j.bbamem.2008.11.024] [Cited by in Crossref: 179] [Cited by in F6Publishing: 187] [Article Influence: 11.9] [Reference Citation Analysis]
535 Choo DW, Baek HJ, Motoyama N, Cho KH, Kim HS, Kim SS. ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation. Biochem Biophys Res Commun 2009;378:847-50. [PMID: 19071090 DOI: 10.1016/j.bbrc.2008.11.132] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
536 Anand P, Kunnumakkara AB, Harikumar KB, Ahn KS, Badmaev V, Aggarwal BB. Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis. Cancer Res 2008;68:8861-70. [PMID: 18974130 DOI: 10.1158/0008-5472.CAN-08-1902] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
537 McHugh PC, Rogers GR, Glubb DM, Allington MD, Hughes M, Joyce PR, Kennedy MA. Downregulation of Ccnd1 and Hes6 in rat hippocampus after chronic exposure to the antidepressant paroxetine. Acta Neuropsychiatr 2008;20:307-13. [PMID: 25384412 DOI: 10.1111/j.1601-5215.2008.00334.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
538 Gonzalez ME, Makarova O, Peterson EA, Privette LM, Petty EM. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal. 2009;21:477-487. [PMID: 19071215 DOI: 10.1016/j.cellsig.2008.11.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
539 Guan H, Williams JF, Ricciardi RP. Induction of neuronal and tumor-related genes by adenovirus type 12 E1A. J Virol 2009;83:651-61. [PMID: 18987153 DOI: 10.1128/JVI.01538-08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
540 Nadiminty N, Gao AC. Mechanisms of selenium chemoprevention and therapy in prostate cancer. Mol Nutr Food Res 2008;52:1247-60. [DOI: 10.1002/mnfr.200700369] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
541 Wang Y, Bian G, Lv X, Zheng R, Sun H, Zhang Z, Chen Y, Li Q, Xiao Y, Yang Q, Ai J, Wei Y, Zhou Q. TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G 1 - to S-phase transition. BMB Reports 2008;41:733-8. [DOI: 10.5483/bmbrep.2008.41.10.733] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
542 Mori K, Hirao E, Toya Y, Oshima Y, Ishikawa F, Nose K, Shibanuma M. Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival. Mol Biol Cell 2009;20:218-32. [PMID: 18946086 DOI: 10.1091/mbc.e08-04-0428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
543 Sanchez-Diaz PC, Burton TL, Burns SC, Hung JY, Penalva LO. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer. 2008;8:280. [PMID: 18826648 DOI: 10.1186/1471-2407-8-280] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
544 Ogba N, Chaplin LJ, Doughman YQ, Fujinaga K, Montano MM. HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb. Cancer Res 2008;68:7015-24. [PMID: 18757415 DOI: 10.1158/0008-5472.CAN-08-0814] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
545 Annen EL, Fitzgerald AC, Gentry PC, McGuire MA, Capuco AV, Baumgard LH, Collier RJ. Effect of continuous milking and bovine somatotropin supplementation on mammary epithelial cell turnover. J Dairy Sci 2007;90:165-83. [PMID: 17183085 DOI: 10.3168/jds.S0022-0302(07)72618-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
546 Theillaumas A, Blanc M, Couderc C, Poncet G, Bazzi W, Bernard C, Cordier-Bussat M, Scoazec JY, Roche C. Relation between menin expression and NF-kappaB activity in an intestinal cell line. Mol Cell Endocrinol 2008;291:109-15. [PMID: 18590796 DOI: 10.1016/j.mce.2008.05.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
547 Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol. 2008;182:509-517. [PMID: 18695042 DOI: 10.1083/jcb.200801079] [Cited by in Crossref: 282] [Cited by in F6Publishing: 300] [Article Influence: 18.8] [Reference Citation Analysis]
548 Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, Kopelovich L, Edelmann W, Jin B, Gravaghi C, Augenlicht L, Kucherlapati R, Lipkin M. Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J Nutr 2008;138:1658-63. [PMID: 18716166 DOI: 10.1093/jn/138.9.1658] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
549 Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008;36:5391-5404. [PMID: 18701644 DOI: 10.1093/nar/gkn522] [Cited by in Crossref: 369] [Cited by in F6Publishing: 388] [Article Influence: 24.6] [Reference Citation Analysis]
550 Wei S, Yang HC, Chuang HC, Yang J, Kulp SK, Lu PJ, Lai MD, Chen CS. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J Biol Chem 2008;283:26759-70. [PMID: 18650423 DOI: 10.1074/jbc.M802160200] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
551 Kakuta H. Necessity is the Mother of Invention: An Ingenious Method for Leukocyte‐Targeted Delivery of siRNA in Stabilized Nanoparticles Demonstrates a Role of Cyclin D1 in Inflammation. ChemMedChem 2008;3:1024-5. [DOI: 10.1002/cmdc.200800095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
552 Korkmaz A, Sanchez-Barcelo EJ, Tan DX, Reiter RJ. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res Treat 2009;115:13-27. [PMID: 18592373 DOI: 10.1007/s10549-008-0103-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
553 Sathyan K, Nalinakumari K, Abraham T, Kannan S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncology 2008;44:689-97. [DOI: 10.1016/j.oraloncology.2007.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
554 Bourdi M, Korrapati MC, Chakraborty M, Yee SB, Pohl LR. Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochem Biophys Res Commun 2008;374:6-10. [PMID: 18586006 DOI: 10.1016/j.bbrc.2008.06.065] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
555 Abu-Ali S, Fotovati A, Shirasuna K. Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers. Mol Cancer 2008;7:47. [PMID: 18519000 DOI: 10.1186/1476-4598-7-47] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
556 Assoian RK, Klein EA. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 2008;18:347-52. [PMID: 18514521 DOI: 10.1016/j.tcb.2008.05.002] [Cited by in Crossref: 186] [Cited by in F6Publishing: 198] [Article Influence: 12.4] [Reference Citation Analysis]
557 Zusso M, Debetto P, Guidolin D, Barbierato M, Manev H, Giusti P. Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochem Pharmacol 2008;76:391-403. [PMID: 18573488 DOI: 10.1016/j.bcp.2008.05.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
558 Mullany LK, White P, Hanse EA, Nelsen CJ, Goggin MM, Mullany JE, Anttila CK, Greenbaum LE, Kaestner KH, Albrecht JH. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 2014;7:2215-24. [DOI: 10.4161/cc.7.14.6274] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
559 Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. Mol Cell Biol 2008;28:4598-608. [PMID: 18474620 DOI: 10.1128/MCB.02192-07] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
560 Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System. The Genetics and Molecular Biology of Neural Tumors. [DOI: 10.1007/978-1-59745-510-7_6] [Reference Citation Analysis]
561 Chen R, Ho Y, Guo H, Wang Y. Rapid Activation of Stat3 and ERK1/2 by Nicotine Modulates Cell Proliferation in Human Bladder Cancer Cells. Toxicological Sciences 2008;104:283-93. [DOI: 10.1093/toxsci/kfn086] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 6.2] [Reference Citation Analysis]
562 Roue G, Pichereau V, Lincet H, Colomer D, Sola B. Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene. 2008;27:4909-4920. [PMID: 18438428 DOI: 10.1038/onc.2008.126] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
563 Ferri N, Granata A, Pirola C, Torti F, Pfister PJ, Dorent R, Corsini A. Fluvastatin Synergistically Improves the Antiproliferative Effect of Everolimus on Rat Smooth Muscle Cells by Altering p27 Kip1 /Cyclin E Expression. Mol Pharmacol 2008;74:144-53. [DOI: 10.1124/mol.108.046045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
564 Sanchez G, Bittencourt D, Laud K, Barbier J, Delattre O, Auboeuf D, Dutertre M. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. Proc Natl Acad Sci U S A 2008;105:6004-9. [PMID: 18413612 DOI: 10.1073/pnas.0710748105] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
565 Jiao S, Liu B, Gao A, Ye M, Jia X, Zhang F, Liu H, Shi X, Huang C. Benzo(a)pyrene-caused increased G1-S transition requires the activation of c-Jun through p53-dependent PI-3K/Akt/ERK pathway in human embryo lung fibroblasts. Toxicol Lett 2008;178:167-75. [PMID: 18448277 DOI: 10.1016/j.toxlet.2008.03.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
566 Marampon F, Casimiro MC, Fu M, Powell MJ, Popov VM, Lindsay J, Zani BM, Ciccarelli C, Watanabe G, Lee RJ, Pestell RG. Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB. Mol Biol Cell 2008;19:2566-78. [PMID: 18367547 DOI: 10.1091/mbc.e06-12-1110] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
567 Catarino R, Pereira D, Breda E, Coelho A, Matos A, Lopes C, Medeiros R. Oncogenic virus-associated neoplasia: a role for cyclin D1 genotypes influencing the age of onset of disease? Biochem Biophys Res Commun 2008;370:118-22. [PMID: 18355450 DOI: 10.1016/j.bbrc.2008.03.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
568 Gunia S, Fritzsche F, May M, Liebe D, Koch S. Do Different Disorders in Cell Cycle Regulation Account for Different Biological Behavior of Urothelial and Sinonasal Inverted Papillomas? Pathobiology 2008;75:34-41. [DOI: 10.1159/000113793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
569 Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Prostate 2008;68:453-61. [PMID: 18196538 DOI: 10.1002/pros.20723] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
570 Bohling SD, Jenson SD, Crockett DK, Schumacher JA, Elenitoba-johnson KS, Lim MS. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma. Leukemia Research 2008;32:383-93. [DOI: 10.1016/j.leukres.2007.07.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
571 García V, García JM, Peña C, Silva J, Domínguez G, Lorenzo Y, Diaz R, Espinosa P, de Sola JG, Cantos B, Bonilla F. Free circulating mRNA in plasma from breast cancer patients and clinical outcome. Cancer Lett 2008;263:312-20. [PMID: 18280643 DOI: 10.1016/j.canlet.2008.01.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 3.5] [Reference Citation Analysis]
572 Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science. 2008;319:627-630. [PMID: 18239128 DOI: 10.1126/science.1149859] [Cited by in Crossref: 389] [Cited by in F6Publishing: 408] [Article Influence: 25.9] [Reference Citation Analysis]
573 Wang W, Wang H, Rayburn ER, Zhao Y, Hill DL, Zhang R. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer 2008;98:792-802. [PMID: 18253123 DOI: 10.1038/sj.bjc.6604227] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 6.3] [Reference Citation Analysis]
574 Itoh S, Kim HW, Nakagawa O, Ozumi K, Lessner SM, Aoki H, Akram K, McKinney RD, Ushio-Fukai M, Fukai T. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J Biol Chem. 2008;283:9157-9167. [PMID: 18245776 DOI: 10.1074/jbc.m709463200] [Cited by in Crossref: 164] [Cited by in F6Publishing: 176] [Article Influence: 10.9] [Reference Citation Analysis]
575 Raven JF, Baltzis D, Wang S, Mounir Z, Papadakis AI, Gao HQ, Koromilas AE. PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2α Phosphorylation. Journal of Biological Chemistry 2008;283:3097-108. [DOI: 10.1074/jbc.m709677200] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 4.7] [Reference Citation Analysis]
576 Yang C, Klein E, Assoian R, Kazanietz M. Heregulin β1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. Biochemical Journal 2008;410:167-75. [DOI: 10.1042/bj20070781] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
577 Jiao X, Katiyar S, Liu M, Mueller SC, Lisanti MP, Li A, Pestell TG, Wu K, Ju X, Li Z, Wagner EF, Takeya T, Wang C, Pestell RG. Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase. Mol Biol Cell 2008;19:1378-90. [PMID: 18216279 DOI: 10.1091/mbc.e07-08-0753] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
578 Li Z, Wang C, Jiao X, Katiyar S, Casimiro MC, Prendergast GC, Powell MJ, Pestell RG. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration. J Biol Chem 2008;283:7007-15. [PMID: 18180298 DOI: 10.1074/jbc.M706992200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
579 Hendy GN, Arnold A. Molecular Basis of PTH Overexpression. Principles of Bone Biology 2008. [DOI: 10.1016/b978-0-12-373884-4.00073-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
580 Dai Y, Grant S. CDK Inhibitors in Multiple Myeloma. Myeloma Therapy 2008. [DOI: 10.1007/978-1-59745-564-0_22] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
581 Casson AG, Schrump DS. BIOLOGY AND EPIDEMIOLOGY OF MALIGNANT ESOPHAGEAL CARCINOMA. Pearson's Thoracic and Esophageal Surgery. Elsevier; 2008. pp. 439-53. [DOI: 10.1016/b978-0-443-06861-4.50191-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
582 Knights CD, Pestell RG. The Cell Cycle. Cancer Drug Discovery and Development. [DOI: 10.1007/978-1-59745-337-0_1] [Reference Citation Analysis]
583 Olshavsky NA, Groh EM, Comstock CE, Morey LM, Wang Y, Revelo MP, Burd C, Meller J, Knudsen KE. Cyclin D3 action in androgen receptor regulation and prostate cancer. Oncogene. 2008;27:3111-3121. [PMID: 18084330 DOI: 10.1038/sj.onc.1210981] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
584 Walisko O, Schorn A, Rolfs F, Devaraj A, Miskey C, Izsvák Z, Ivics Z. Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol Ther 2008;16:359-69. [PMID: 18071335 DOI: 10.1038/sj.mt.6300366] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 4.3] [Reference Citation Analysis]
585 Goissis M, Caetano H, Marques M, de Barros F, Feitosa W, Milazzotto M, Binelli M, Assumpção M, Visintin J. Effects of Serum Deprivation and Cycloheximide on Cell Cycle of Low and High Passage Porcine Fetal Fibroblasts. Reprod Domest Anim 2007;42:660-3. [DOI: 10.1111/j.1439-0531.2006.00839.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
586 Lassmann S, Tang L, Capanu M, Brabletz T, Schöpflin A, Zur Hausen A, Gonen M, Kemeny N, Shia J, Klimstra D, Werner M. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology 2007;133:1831-9. [PMID: 18054556 DOI: 10.1053/j.gastro.2007.08.075] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
587 Tonini G, Pantano F, Vincenzi B, Gabbrielli A, Coppola R, Santini D. Molecular prognostic factors in patients with pancreatic cancer. Expert Opinion on Therapeutic Targets 2007;11:1553-69. [DOI: 10.1517/14728222.11.12.1553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
588 Powell MJ, Popov VM, Wang C, Pestell RG. Nuclear Receptors and Cyclins in Hormone Signaling. Hormonal Control of Cell Cycle. [DOI: 10.1007/978-3-540-73855-8_3] [Reference Citation Analysis]
589 Borlon C, Godard P, Eskes C, Hartung T, Zuang V, Toussaint O. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis. Toxicology 2007;241:157-66. [DOI: 10.1016/j.tox.2007.08.096] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
590 Takahashi-Yanaga F, Sasaguri T. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 2008;20:581-9. [PMID: 18023328 DOI: 10.1016/j.cellsig.2007.10.018] [Cited by in Crossref: 189] [Cited by in F6Publishing: 200] [Article Influence: 11.8] [Reference Citation Analysis]
591 Bawa-Khalfe T, Cheng J, Wang Z, Yeh ET. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells. J Biol Chem 2007;282:37341-9. [PMID: 17932034 DOI: 10.1074/jbc.M706978200] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.9] [Reference Citation Analysis]
592 Roy AL. Signal-induced functions of the transcription factor TFII-I. Biochim Biophys Acta 2007;1769:613-21. [PMID: 17976384 DOI: 10.1016/j.bbaexp.2007.10.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
593 Ding S, McEntee MF, Whelan J, Zemel M. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium. Nutr Cancer 2007;58:153-61. [PMID: 17640161 DOI: 10.1080/01635580701328248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
594 Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res 2007;17:324-32. [PMID: 17372613 DOI: 10.1038/cr.2007.10] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.6] [Reference Citation Analysis]
595 Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007;7:750-62. [PMID: 17891190 DOI: 10.1038/nrc2230] [Cited by in Crossref: 371] [Cited by in F6Publishing: 389] [Article Influence: 23.2] [Reference Citation Analysis]
596 Chachami G, Hatziefthimiou A, Liakos P, Ioannou MG, Koukoulis GK, Bonanou S, Molyvdas P, Simos G, Paraskeva E. Exposure of differentiated airway smooth muscle cells to serum stimulates both induction of hypoxia-inducible factor-1α and airway responsiveness to ACh. American Journal of Physiology-Lung Cellular and Molecular Physiology 2007;293:L913-22. [DOI: 10.1152/ajplung.00459.2006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
597 Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc Natl Acad Sci U S A 2007;104:13438-43. [PMID: 17679696 DOI: 10.1073/pnas.0701990104] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
598 Altiok N, Mezzadra H, Patel P, Koyuturk M, Altiok S. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1. Breast Cancer Res Treat 2008;109:315-23. [DOI: 10.1007/s10549-007-9658-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
599 Caldon CE, Lee CS, Sutherland RL, Musgrove EA. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation. Oncogene 2008;27:126-38. [PMID: 17599043 DOI: 10.1038/sj.onc.1210622] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
600 Izzo JG, Luthra R, Wu TT, Correa AM, Luthra M, Anandasabapathy S, Chao KS, Hung MC, Aggarwal B, Hittelman WN, Ajani JA. Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol 2007;34:S2-6. [PMID: 17449347 DOI: 10.1053/j.seminoncol.2007.01.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
601 Kikuchi H, Uchida C, Hattori T, Isobe T, Hiramatsu Y, Kitagawa K, Oda T, Konno H, Kitagawa M. ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells. Carcinogenesis 2007;28:1752-8. [PMID: 17510080 DOI: 10.1093/carcin/bgm120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
602 Gao W, Bussom S, Grill SP, Gullen EA, Hu YC, Huang X, Zhong S, Kaczmarek C, Gutierrez J, Francis S, Baker DC, Yu S, Cheng YC. Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett 2007;17:4338-42. [PMID: 17531481 DOI: 10.1016/j.bmcl.2007.05.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
603 Vikhanskaya F, Toh WH, Dulloo I, Wu Q, Boominathan L, Ng HH, Vousden KH, Sabapathy K. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol 2007;9:698-705. [PMID: 17496887 DOI: 10.1038/ncb1598] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
604 Comstock CE, Revelo MP, Buncher CR, Knudsen KE. Impact of differential cyclin D1 expression and localisation in prostate cancer. Br J Cancer. 2007;96:970-979. [PMID: 17375037 DOI: 10.1038/sj.bjc.6603615] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
605 Bostner J, Ahnström Waltersson M, Fornander T, Skoog L, Nordenskjöld B, Stål O. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene 2007;26:6997-7005. [PMID: 17486065 DOI: 10.1038/sj.onc.1210506] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 6.9] [Reference Citation Analysis]
606 Corbetta S, Eller-Vainicher C, Vicentini L, Lania A, Mantovani G, Beck-Peccoz P, Spada A. Modulation of cyclin D1 expression in human tumoral parathyroid cells: effects of growth factors and calcium sensing receptor activation. Cancer Lett. 2007;255:34-41. [PMID: 17482347 DOI: 10.1016/j.canlet.2007.03.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
607 Cheung IY, Feng Y, Vickers A, Gerald W, Cheung NK. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. J Mol Diagn 2007;9:237-41. [PMID: 17384216 DOI: 10.2353/jmoldx.2007.060130] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
608 Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, Anania FA. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497-2507. [PMID: 17363567 DOI: 10.1158/0008-5472.can-06-3075] [Cited by in Crossref: 344] [Cited by in F6Publishing: 366] [Article Influence: 21.5] [Reference Citation Analysis]
609 Fu D, Richardson DR. Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood 2007;110:752-61. [PMID: 17429006 DOI: 10.1182/blood-2007-03-076737] [Cited by in Crossref: 104] [Cited by in F6Publishing: 106] [Article Influence: 6.5] [Reference Citation Analysis]
610 Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer. 2007;6:24. [PMID: 17407548 DOI: 10.1186/1476-4598-6-24] [Cited by in Crossref: 522] [Cited by in F6Publishing: 563] [Article Influence: 32.6] [Reference Citation Analysis]
611 Jeng YJ, Suarez VR, Izban MG, Wang HQ, Soloff MS. Progesterone-induced sphingosine kinase-1 expression in the rat uterus during pregnancy and signaling consequences. Am J Physiol Endocrinol Metab 2007;292:E1110-21. [PMID: 17164439 DOI: 10.1152/ajpendo.00373.2006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
612 Alama A, Barbieri F, Spaziante R, Bruzzo C, Dadati P, Dorcaratto A, Ravetti JL. Significance of cyclin D1 expression in meningiomas: A preliminary study. Journal of Clinical Neuroscience 2007;14:355-8. [DOI: 10.1016/j.jocn.2006.04.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
613 Watts KL, Cottrell E, Hoban PR, Spiteri MA. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis. Respir Res. 2006;7:88. [PMID: 17273773 DOI: 10.1186/1465-9921-7-88] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
614 Böhm J, Kaiser FJ, Borozdin W, Depping R, Kohlhase J. Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repression. Biochem Biophys Res Commun 2007;356:773-9. [PMID: 17383611 DOI: 10.1016/j.bbrc.2007.03.050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
615 Liu S, Tan WY, Chen QR, Chen XP, Fu K, Zhao YY, Chen ZW. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci. 2008;99:952-957. [PMID: 18341653 DOI: 10.1111/j.1349-7006.2008.00787.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
616 Saxena NK, Vertino PM, Anania FA, Sharma D. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 2007;282:13316-25. [PMID: 17344214 DOI: 10.1074/jbc.M609798200] [Cited by in Crossref: 144] [Cited by in F6Publishing: 156] [Article Influence: 9.0] [Reference Citation Analysis]
617 Takahashi M, Kojima M, Nakajima K, Suzuki-migishima R, Takeuchi T. Functions of a jumonji–cyclin D1 pathway in the coordination of cell cycle exit and migration during neurogenesis in the mouse hindbrain. Developmental Biology 2007;303:549-60. [DOI: 10.1016/j.ydbio.2006.11.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
618 Ramdass B, Maliekal TT, Lakshmi S, Rehman M, Rema P, Nair P, Mukherjee G, Reddy B, Krishna S, Radhakrishna Pillai M. Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecologic Oncology 2007;104:352-61. [DOI: 10.1016/j.ygyno.2006.08.054] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
619 Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2007;148:868-77. [PMID: 17082259 DOI: 10.1210/en.2006-0687] [Cited by in Crossref: 241] [Cited by in F6Publishing: 239] [Article Influence: 15.1] [Reference Citation Analysis]
620 Nurtjahja-Tjendraputra E, Fu D, Phang JM, Richardson DR. Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 2007;109:4045-54. [PMID: 17197429 DOI: 10.1182/blood-2006-10-047753] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 6.5] [Reference Citation Analysis]
621 Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am J Pathol 2006;169:1784-801. [PMID: 17071600 DOI: 10.2353/ajpath.2006.060590] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
622 Catarino RJ, Breda E, Coelho V, Pinto D, Sousa H, Lopes C, Medeiros R. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 2006;28:603-8. [PMID: 16691558 DOI: 10.1002/hed.20377] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
623 Fu L, Patel MS, Karsenty G. The circadian modulation of leptin-controlled bone formation. Prog Brain Res 2006;153:177-88. [PMID: 16876575 DOI: 10.1016/S0079-6123(06)53010-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
624 Sridhar J, Rosen E, Pestell R, Pattabiraman N. CDK Inhibitors as Anticancer Agents. Enzyme Inhibitors Series 2006. [DOI: 10.1201/9781420005400.ch18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
625 Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, Morimoto S, Sasaguri T. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. J Biol Chem. 2006;281:38489-38497. [PMID: 17046823 DOI: 10.1074/jbc.m605205200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
626 Magariños MP, Sánchez-Margalet V, Kotler M, Calvo JC, Varone CL. Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 2007;76:203-10. [PMID: 17021346 DOI: 10.1095/biolreprod.106.051391] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
627 Park SG, Chung C, Kang H, Kim J, Jung G. Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter. Journal of Biological Chemistry 2006;281:31770-7. [DOI: 10.1016/s0021-9258(19)84092-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
628 Upton JW, Speck SH. Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin. J Virol 2006;80:11946-59. [PMID: 17005668 DOI: 10.1128/JVI.01722-06] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
629 Porubleva LV. Molecular mechanisms of telomerase activity regulation. Biopolym Cell 2006;22:323-338. [DOI: 10.7124/bc.000740] [Reference Citation Analysis]
630 Cheng J, Bawa T, Lee P, Gong L, Yeh ET. Role of desumoylation in the development of prostate cancer. Neoplasia 2006;8:667-76. [PMID: 16925949 DOI: 10.1593/neo.06445] [Cited by in Crossref: 162] [Cited by in F6Publishing: 170] [Article Influence: 9.5] [Reference Citation Analysis]
631 Park SG, Chung C, Kang H, Kim JY, Jung G. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J Biol Chem. 2006;281:31770-31777. [PMID: 16940298 DOI: 10.1074/jbc.M603194200] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
632 Li H, Goswami PC, Domann FE. AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells. Neoplasia 2006;8:568-77. [PMID: 16867219 DOI: 10.1593/neo.06367] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
633 Sommerfeldt N, Schütz F, Sohn C, Förster J, Schirrmacher V, Beckhove P. The Shaping of a Polyvalent and Highly Individual T-Cell Repertoire in the Bone Marrow of Breast Cancer Patients. Cancer Research 2006;66:8258-8265. [DOI: 10.1158/0008-5472.can-05-4201] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
634 Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, Wang C, Byers S, Nicholson R, Link T, Shemluck M, Yang J, Fricke ST, Novikoff PM, Papanikolaou A, Arnold A, Albanese C, Pestell R. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006;26:5449-69. [PMID: 16809779 DOI: 10.1128/MCB.02074-05] [Cited by in Crossref: 132] [Cited by in F6Publishing: 141] [Article Influence: 7.8] [Reference Citation Analysis]
635 Christie DB, Kang J, Ashley DW, Mix W, Lochner FK, Solis MM, Newman WH, Dalton ML, Wang Z. Accelerated migration and proliferation of smooth muscle cells cultured from neointima induced by a vena cava filter. Am Surg 2006;72:491-6. [PMID: 16808200 DOI: 10.1177/000313480607200606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
636 Wikman H, Kettunen E. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev Anticancer Ther 2006;6:515-30. [PMID: 16613540 DOI: 10.1586/14737140.6.4.515] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
637 Gu J, Wu X, Dong Q, Romeo MJ, Lin X, Gutkind JS, Berman DM. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer 2006;106:2716-24. [PMID: 16691626 DOI: 10.1002/cncr.21944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
638 Jagadeesh S, Banerjee PP. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun 2006;347:774-80. [PMID: 16843438 DOI: 10.1016/j.bbrc.2006.06.172] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
639 Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 2006;168:1998-2013. [PMID: 16723714 DOI: 10.2353/ajpath.2006.051089] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 4.5] [Reference Citation Analysis]
640 Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol 2006;19:999-1009. [PMID: 16648863 DOI: 10.1038/modpathol.3800621] [Cited by in Crossref: 116] [Cited by in F6Publishing: 124] [Article Influence: 6.8] [Reference Citation Analysis]
641 Gerlach U, Kayser G, Walch A, Hopt U, Schulte-Mönting J, Werner M, Lassmann S. Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. J Pathol 2006;208:462-72. [PMID: 16402339 DOI: 10.1002/path.1914] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
642 Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 2006;26:4240-56. [PMID: 16705174 DOI: 10.1128/MCB.02124-05] [Cited by in Crossref: 140] [Cited by in F6Publishing: 146] [Article Influence: 8.2] [Reference Citation Analysis]
643 Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K, Balda MS. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA. Mol Cell Biol 2006;26:2387-98. [PMID: 16508013 DOI: 10.1128/MCB.26.6.2387-2398.2006] [Cited by in Crossref: 166] [Cited by in F6Publishing: 174] [Article Influence: 9.8] [Reference Citation Analysis]
644 Pan Q, Bao LW, Teknos TN, Merajver SD. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma. Cancer Res. 2006;66:9379-9384. [PMID: 16776827 DOI: 10.1158/0008-5472.can-06-2646] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 3.2] [Reference Citation Analysis]
645 Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T, Tsuda H. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas. Carcinogenesis 2006;27:2497-510. [PMID: 16774944 DOI: 10.1093/carcin/bgl090] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
646 Lin YF, Wu MS, Chang CC, Lin SW, Lin JT, Sun YJ, Chen DS, Chow LP. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics. 2006;5:1484-1496. [PMID: 16769709 DOI: 10.1074/mcp.m600111-mcp200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
647 Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem 2006;97:261-74. [PMID: 16267837 DOI: 10.1002/jcb.20690] [Cited by in Crossref: 150] [Cited by in F6Publishing: 163] [Article Influence: 8.8] [Reference Citation Analysis]
648 Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006;25:6291-303. [PMID: 16732330 DOI: 10.1038/sj.onc.1209644] [Cited by in Crossref: 99] [Cited by in F6Publishing: 106] [Article Influence: 5.8] [Reference Citation Analysis]
649 Coe BP, Lockwood WW, Girard L, Chari R, Macaulay C, Lam S, Gazdar AF, Minna JD, Lam WL. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer 2006;94:1927-35. [PMID: 16705311 DOI: 10.1038/sj.bjc.6603167] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 3.4] [Reference Citation Analysis]
650 Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene 2006;25:5517-26. [PMID: 16619035 DOI: 10.1038/sj.onc.1209563] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
651 Chun KH, Lotan R. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells. Cell Death Differ 2006;13:1830-2. [PMID: 16601752 DOI: 10.1038/sj.cdd.4401917] [Reference Citation Analysis]
652 Alarcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006;25:722-34. [PMID: 16302003 DOI: 10.1038/sj.onc.1209112] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.5] [Reference Citation Analysis]
653 Habuchi T. Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model. Future Oncology 2006;2:233-45. [DOI: 10.2217/14796694.2.2.233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
654 Burnworth B, Popp S, Stark HJ, Steinkraus V, Bröcker EB, Hartschuh W, Birek C, Boukamp P. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 2006;25:4399-412. [PMID: 16547504 DOI: 10.1038/sj.onc.1209474] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
655 Zhang D, Trudeau VL. Integration of membrane and nuclear estrogen receptor signaling. Comp Biochem Physiol A Mol Integr Physiol 2006;144:306-15. [PMID: 16516516 DOI: 10.1016/j.cbpa.2006.01.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 4.0] [Reference Citation Analysis]
656 Kandel R, Li SQ, Bell R, Wunder J, Ferguson P, Kauzman A, Diehl JA, Werier J. Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors. J Orthop Res 2006;24:428-37. [PMID: 16479604 DOI: 10.1002/jor.20036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
657 Hashiramoto A, Mizukami H, Yamashita T. Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1. Oncogene 2006;25:3948-55. [PMID: 16491123 DOI: 10.1038/sj.onc.1209416] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
658 Calonghi N, Pagnotta E, Parolin C, Tognoli C, Boga C, Masotti L. 9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma. Biochem Biophys Res Commun 2006;342:585-8. [PMID: 16487928 DOI: 10.1016/j.bbrc.2006.02.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
659 Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, Rosenberg N, Prives C, Roy AL. Inhibition of TFII-I-dependent cell cycle regulation by p53. Mol Cell Biol 2005;25:10940-52. [PMID: 16314517 DOI: 10.1128/MCB.25.24.10940-10952.2005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
660 Stubbs S, Thomas N. Dynamic Green Fluorescent Protein Sensors for High‐Content Analysis of the Cell Cycle. Measuring Biological Responses with Automated Microscopy. Elsevier; 2006. pp. 1-21. [DOI: 10.1016/s0076-6879(06)14001-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
661 Węsierska-gądek J. Endocrine disruptor contaminants in water and their adverse effects in humans. Ecohydrology & Hydrobiology 2006;6:233-42. [DOI: 10.1016/s1642-3593(06)70147-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
662 Rao A, Ray M, Rao L. Lycopene. Advances in Food and Nutrition Research 2006. [DOI: 10.1016/s1043-4526(06)51002-2] [Cited by in Crossref: 155] [Cited by in F6Publishing: 163] [Article Influence: 9.1] [Reference Citation Analysis]
663 Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 2006;9:13-22. [PMID: 16413468 DOI: 10.1016/j.ccr.2005.12.019] [Cited by in Crossref: 231] [Cited by in F6Publishing: 243] [Article Influence: 13.6] [Reference Citation Analysis]
664 Wu BK, Li CC, Chen HJ, Chang JL, Jeng KS, Chou CK, Hsu MT, Tsai TF. Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun. 2006;340:916-928. [PMID: 16403455 DOI: 10.1016/j.bbrc.2005.12.089] [Cited by in Crossref: 92] [Cited by in F6Publishing: 99] [Article Influence: 5.1] [Reference Citation Analysis]
665 Hess-wilson J, Boldison J, Weaver K, Knudsen K. Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res Treat 2006;96:279-92. [DOI: 10.1007/s10549-005-9082-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
666 Janknecht R. EWS–ETS oncoproteins: The linchpins of Ewing tumors. Gene 2005;363:1-14. [DOI: 10.1016/j.gene.2005.08.007] [Cited by in Crossref: 127] [Cited by in F6Publishing: 136] [Article Influence: 7.1] [Reference Citation Analysis]
667 Weroha SJ, Li SA, Tawfik O, Li JJ. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 2006;27:491-8. [PMID: 16311245 DOI: 10.1093/carcin/bgi278] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
668 Chang P, Chi C, Chau G, Li F, Tsai Y, Wu J, Wu Lee Y. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006;25:1991-2003. [DOI: 10.1038/sj.onc.1209239] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 5.9] [Reference Citation Analysis]
669 Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 2005;122:803-15. [PMID: 16143109 DOI: 10.1016/j.cell.2005.06.028] [Cited by in Crossref: 429] [Cited by in F6Publishing: 444] [Article Influence: 23.8] [Reference Citation Analysis]
670 Mori J, Takahashi-yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. Experimental Cell Research 2005;310:426-33. [DOI: 10.1016/j.yexcr.2005.07.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
671 Kim YT, Zhao M. Aberrant cell cycle regulation in cervical carcinoma. Yonsei Med J 2005;46:597-613. [PMID: 16259056 DOI: 10.3349/ymj.2005.46.5.597] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
672 Yasmin T, Takahashi-Yanaga F, Mori J, Miwa Y, Hirata M, Watanabe Y, Morimoto S, Sasaguri T. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells. Biochem Biophys Res Commun. 2005;338:903-909. [PMID: 16243295 DOI: 10.1016/j.bbrc.2005.10.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
673 Misikangas M, Pajari AM, Päivärinta E, Mutanen M. Promotion of adenoma growth by dietary inulin is associated with increase in cyclin D1 and decrease in adhesion proteins in Min/+ mice mucosa. J Nutr Biochem 2005;16:402-9. [PMID: 15992678 DOI: 10.1016/j.jnutbio.2005.01.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
674 Macaluso M, Montanari M, Cinti C, Giordano A. Modulation of Cell Cycle Components by Epigenetic and Genetic Events. Seminars in Oncology 2005;32:452-7. [DOI: 10.1053/j.seminoncol.2005.07.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 3.5] [Reference Citation Analysis]
675 Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L, Huang AM, Sterneck E. C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 2005;132:4675-85. [PMID: 16192306 DOI: 10.1242/dev.02050] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
676 Casson AG, Zheng Z, Evans SC, Geldenhuys L, van Zanten SV, Veugelers PJ, Porter GA, Guernsey DL. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer. 2005;104:730-739. [PMID: 15971196 DOI: 10.1002/cncr.21229] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 2.7] [Reference Citation Analysis]
677 Hayes VM. Review of: Association of cyclin D1 genotype with breast cancer risk and survival. Breast Cancer Online 2005;8:e50. [DOI: 10.1017/s1470903105004438] [Reference Citation Analysis]
678 Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, Li Z, Jiao X, Yang J, Li A. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem. 2005;280:29728-29742. [PMID: 15951563 DOI: 10.1074/jbc.M503188200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 4.1] [Reference Citation Analysis]
679 Bu X, Avraham HK, Li X, Lim B, Jiang S, Fu Y, Pestell RG, Avraham S. Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells. Oncogene 2005;24:2398-409. [PMID: 15735724 DOI: 10.1038/sj.onc.1208466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
680 Chi-shern Ho B, Hoon Tan P. Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology 2005;37:105-11. [DOI: 10.1080/00313020500058532] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
681 De Falco M, Fedele V, De Luca L, Penta R, Cottone G, Cavallotti I, Laforgia V, De Luca A. Evaluation of cyclin D1 expression and its subcellular distribution in mouse tissues. J Anat 2004;205:405-12. [PMID: 15575889 DOI: 10.1111/j.0021-8782.2004.00347.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
682 Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao TP, Pestell RG. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem. 2005;280:16934-16941. [PMID: 15713663 DOI: 10.1074/jbc.m500403200] [Cited by in Crossref: 219] [Cited by in F6Publishing: 226] [Article Influence: 12.2] [Reference Citation Analysis]
683 Yan R, Tian H, Du Z. Quercetin protects PC-12 cells against hypoxia injury by down-regulation of miR-122. Iran J Basic Med Sci 2019;22:391-8. [PMID: 31168343 DOI: 10.22038/ijbms.2019.30224.7287] [Cited by in F6Publishing: 2] [Reference Citation Analysis]